Document:

exv4w2

 

Exhibit 4.2

FORM OF

EXCHANGE AND SHAREHOLDER RIGHTS AGREEMENT

dated as of                     , 2007

by and among

FREMONT GENERAL CORPORATION,

FREMONT INVESTMENT & LOAN

and

HUNTER’S GLEN/FORD, LTD.

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page
	 	 	 	 	 	 	 
	1.	 	Certain Definitions	 	 	1	 
	2.	 	Exchange, Put and Call	 	 	6	 
	 

	 	(a)
	 	Exchange at the Option of the Holder
	 	 	6	 
	 

	 	(b)
	 	Change of Control
	 	 	7	 
	 

	 	(c)
	 	Exchange Price
	 	 	8	 
	 

	 	(d)
	 	Fractional Shares
	 	 	8	 
	 

	 	(e)
	 	Adjustments to Exchange Price and Exchange Features
	 	 	9	 
	 

	 	(f)
	 	Exchange Mechanics
	 	 	15	 
	 

	 	(g)
	 	Notice of Adjustment of Exchange Price
	 	 	16	 
	 

	 	(h)
	 	Company to Reserve Common Stock
	 	 	16	 
	 

	 	(i)
	 	Taxes on Exchange
	 	 	17	 
	 

	 	(j)
	 	Compliance with Law
	 	 	17	 
	3.	 	Governance	 	 	17	 
	 

	 	(a)
	 	Composition of the Board of Directors
	 	 	17	 
	 

	 	(b)
	 	Company Officers
	 	 	18	 
	4.	 	Transfer Restrictions and Restricted Payments	 	 	18	 
	 

	 	(a)
	 	Transfers to Permitted Holders
	 	 	18	 
	 

	 	(b)
	 	Warrant
	 	 	19	 
	 

	 	(c)
	 	Series A Preferred Stock
	 	 	19	 
	 

	 	(d)
	 	Common Stock
	 	 	20	 
	 

	 	(e)
	 	Legend on Securities
	 	 	21	 
	 

	 	(f)
	 	Restrictions on Redemptions, Dividends and Distributions
	 	 	22	 
	 

	 	(g)
	 	Standstill
	 	 	22	 
	5.	 	Miscellaneous	 	 	23	 
	 

	 	(a)
	 	Fees and Expenses
	 	 	23	 
	 

	 	(b)
	 	Notices
	 	 	23	 
	 

	 	(c)
	 	Entire Agreement
	 	 	24	 
	 

	 	(d)
	 	Amendments
	 	 	24	 
	 

	 	(e)
	 	Counterparts
	 	 	25	 
	 

	 	(f)
	 	Governing Law
	 	 	25	 
	 

	 	(g)
	 	Successors and Assigns
	 	 	25	 
	 

	 	(h)
	 	Remedies; Waiver
	 	 	25	 
	 

	 	(i)
	 	Specific Performance; Consent to Jurisdiction
	 	 	25	 
	 

	 	(j)
	 	Severability
	 	 	25	 
	 

	 	(k)
	 	Survival
	 	 	26	 
	 

	 	(l)
	 	Joinder Agreements
	 	 	26	 

EXHIBIT A — EXCHANGE NOTICE

(i)

 

          EXCHANGE AND SHAREHOLDER RIGHTS AGREEMENT dated as of [•], 2007 by and among Fremont
General Corporation, a Nevada corporation (the “Company”), Fremont Investment & Loan, a
California industrial banking corporation (the “Bank”), and Hunter’s Glen/Ford, Ltd., a
Texas limited partnership (together with its Affiliates, the “Investor”).

WITNESSETH:

          WHEREAS, the Company, the Bank and the Investor have each determined to enter into this
Agreement in connection with the Investment Agreement pursuant to which the Investor has agreed,
among other things, to purchase from the Bank, and the Bank has agreed to issue and sell to the
Investor, 8,899,410 shares of its 6.5% Series A Non-Cumulative Exchangeable Preferred Stock (the
“Series A Preferred Stock”).

          WHEREAS, the Series A Preferred Stock is exchangeable for shares of Common Stock as set forth
herein.

          NOW, THEREFORE, in consideration of the premises and the mutual representations, warranties,
covenants and agreements contained herein, the parties hereto hereby agree as follows:

     1. Certain Definitions.

          In addition to the terms defined elsewhere in this Agreement, the following terms shall have
the following meanings:

          “Additional Holder Nominee” has the meaning assigned to it in Section 3(a)(6) hereof.

          “Additional Warrant” means the warrant, substantially in the form of the Original
Warrant (modified to reflect receipt of Shareholder Approval), to be issued by the Company to the
Investor pursuant to the Investment Agreement upon receipt of the approval of the Company’s
shareholders thereof to acquire up to 4,004,680 shares of Common Stock (plus the number of shares,
if any, that are subtracted from the Original Warrant Shares and Exchange Shares (as defined in the
Investment Agreement) for purposes of the NYSE listing standards and regulations).

          “Affiliate” of a Person has the meaning set forth in Rule 12b-2 under the Exchange
Act.

          “Aggregate Initial Shares” means the aggregate number of (i) shares of Common Stock
that may be acquired by the Investor (or its Affiliates) upon exchange of all Series A Preferred
Stock purchased by the Investor (or its Affiliates) at the Closing based upon the Exchange Price in
effect on the Closing Date (such number to be appropriately adjusted for the events described in
Sections 2(e)(6) and 2(e)(7)) and (ii) Warrant Shares actually issued upon exercise of the Warrants
by the Investor and its Affiliates. For purposes of Section 3, Aggregate Initial Shares shall
exclude any shares of Common Stock and Series A Preferred Stock

1

 

Transferred by the Investor or its Affiliate to another Permitted Holder that is not an
Affiliate of the Investor.

          “Applicable Base Amount” shall mean $8.44 from the date hereof to (but excluding) the
Shareholder Approval Date, and shall mean $9.00 from (and including) and after the Shareholder
Approval Date.

          “Applicable Percentage” shall mean 75% from the date hereof to (but excluding) the
Shareholder Approval Date, and shall mean 85% from (and including) and after the Shareholder
Approval Date.

          “Asset Purchase Agreement” means the Asset Purchase Agreement, dated as of May 21,
2007, between the Bank and iStar Financial Inc.

          “Automatic Exchange Date” has the meaning assigned to it in Section 2(b) hereof.

          “Automatic Exchange Payment” has the meaning assigned to it in Section 2(b) hereof.

          “Bank” has the meaning assigned to it in the preamble.

          “Base Dividends” has the meaning assigned to it in the Certificate of Determination.

          “Beneficially Own” with respect to any securities means having “beneficial ownership”
of such securities (as determined pursuant to Rule 13d-3 under the Exchange Act, as in effect on
the date hereof, without regard to the 60-day provision in paragraph (d)(1)(i) thereof). The terms
“Beneficial Ownership” and “Beneficial Owner” have correlative meanings. For the
avoidance of doubt, any Person will be deemed to Beneficially Own (a) all shares of Common Stock
(as hereinafter defined) issuable upon exchange of the Series A Preferred Stock owned by such
Person and its Affiliates in accordance with this Agreement and (b) all shares of Common Stock that
may be purchased upon exercise of the Warrants held by such Person and its Affiliates.

          “Board of Directors” means the Board of Directors of the Company.

          “Business Day” means any day, other than a Saturday, Sunday or a day on which banking
institutions in the State of California are authorized or obligated by law or executive order to
close.

          “CDI Litigation” means pending litigation (and related actions) brought against the
Company, its subsidiaries or its officers and directors by the California Insurance Commissioner
alleging, among other things, the improper utilization by the Company or its subsidiary of certain
net operating loss deductions and mismanagement claims.

          “Certificate of Determination” has the meaning assigned to it in the Investment
Agreement.

2

 

          “Change of Control” means any event or transaction or series of events or transactions
pursuant to which

	 	•	 	any Person or “group” (as defined in Section 13(d)(3) of the Exchange Act),
and the rules thereunder) other than any Permitted Holder and its Affiliates,
acquires beneficial ownership of more than 25% of the outstanding voting
securities of the Company;
	 
	 	•	 	any Person or “group” (as defined in Section 13(d)(3) of the Exchange Act
and the rules thereunder) other than any Permitted Holder and its Affiliates,
acquires beneficial ownership of more than 25% of the outstanding voting
securities of the Bank;
	 
	 	•	 	the execution by the Company or the Bank of one or more agreements to sell
all or substantially all of its assets.

          “Change of Control Notice” has the meaning assigned to it in Section 2(b) hereof.

          “Closing Date” means the date of closing of the Investor’s purchase of the Series A
Preferred Stock and the Original Warrant.

          “Closing Price” means, for each trading day, the last reported sale price regular way
on the principal national securities exchange on which the Common Stock is then listed or admitted
for trading or, if the Common Stock is not listed on a national securities exchange, the average of
the closing bid and asked prices in the over-the-counter market as furnished by any New York Stock
Exchange member firm selected from time to time by the Company for that purpose.

          “Commercial Real Estate Transaction” has the meaning assigned to it in the Investment
Agreement.

          “Commission” means the Securities and Exchange Commission.

          “Common Stock” means the common stock, par value $1.00 per share, of the Company.

          “Company” has the meaning assigned to it in the preamble.

          “Conversion Amount” has the meaning assigned to it in Section 2(a) hereof.

          “Current Market Price” means, on any day, the average of the Closing Prices of the
Common Stock for the ten consecutive trading days ending on such date.

          “Exchange Act” means the Securities and Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder

          “Exchange Date” has the meaning assigned to it in Section 2(f) hereof.

3

 

          “Exchange Notice” has the meaning assigned to it in Section 2(f) hereof.

          “Exchange Price” has the meaning assigned to it in Section 2(c) hereof.

          “Excluded Stock” has the meaning assigned to it in Section 2(e)(11) hereof.

          “Exercise Price” means the exercise price to purchase one share of Common Stock
pursuant to the Warrants.

          “Fair Market Value” means the amount which a willing buyer would pay a willing seller
in an arms-length transaction, as determined in good faith by the Board of Directors.

          “Fully Diluted Outstanding Shares” as of any date means the number of shares of Common
Stock outstanding on such date on a fully diluted basis (including, without limitation, shares of
restricted stock (whether or not vested) and, in accordance with the treasury method, shares
subject to outstanding stock options, whether or not “in the money”), excluding shares issued or
issuable upon exchange of Series A Preferred Stock or upon exercise of Warrants.

          “Holders” has the meaning assigned to it in Section 2(a) hereof.

          “Initial Investor Nominee” and “Investor Nominees” have the meanings assigned
to them in Section 3(a)(1).

          “Investment Agreement” means the Investment Agreement, dated as of May 21, 2007, by
and among the Company, the Bank and the Investor.

          “Investor” has the meaning assigned to it in the preamble.

          “Liquidation Preference” has the meaning assigned to it in the Certificate of
Determination.

          “Litigation Cost Excess” has the meaning assigned to it in Section 2(e)(2) hereof.

          “Litigation Costs” has the meaning assigned to it in Section 2(e)(2) hereof.

          “Litigation Resolution Date” has the meaning assigned to it in Section 2(e)(2) hereof.

          “Litigation Settlement Amount” has the meaning assigned to it in Section 2(e)(2)
hereof.

          “Loan Losses” has the meaning assigned to it in Section 2(e)(3) hereof.

          “Loan Loss Excess” has the meaning assigned to it in Section 2(e)(3) hereof.

          “Loan Loss Settlement Amount” has the meaning assigned to it in Section 2(e)(3)
hereof.

4

 

          “Measurement Date” has the meaning assigned to it in the definition of “Reset Date.”

          “Original Issue Date” means the date on which the Series A Preferred Stock was issued
by the Bank pursuant to the Investment Agreement.

          “Original Warrant” means the warrant to purchase 7,129,326 shares of Common Stock
issued to the Investor on the date hereof.

          “Permitted Holders” has the meaning assigned to it in the Investment Agreement.

          “Person” means any natural person, firm, partnership, limited liability company,
association, corporation, company, trust, business trust, governmental agency or other entity.

          “Premium” means the amount to be paid for the Purchased Non-Loan Assets as defined in
the Asset Purchase Agreement pursuant to Section 2.04(b) therein or any successor provisions, not
to exceed $50,000,000.

          “Qualified Transferee” means an “accredited investor” as defined in Rule 501 under the
Securities Act.

          “Quarter-End Date” has the meaning assigned to it in the definition of Reset Date.

          “Representatives” means, with respect to any Person, any of such Person’s officers,
directors, employees, agents, attorneys, accountants, consultants or financial or other advisors or
other Person associated with or acting on behalf of such Person.

          “Reset Date” means the date that is the 45th day after the earlier to occur
of (i) the last day of the Company’s fiscal quarter during which the Bank consummates the
Commercial Real Estate Transaction (the “Quarter-End Date”) and (ii) December 31, 2007 (the
“Year-End”) (the earlier to occur of the Quarter-End Date and the Year-End being referred
to herein as the “Measurement Date”).

          “Securities Act” means the Securities Act of 1933, as amended, and the regulations
promulgated thereunder.

          “Series A Preferred Stock” has the meaning assigned to it in the preamble.

          “Shareholder Approval” means the approval by the Company’s shareholders of the
Additional Warrant.

          “Shareholder Approval Date” means the date as of which the Shareholder Approval
occurs.

          “Tangible Book Value” means the positive difference, if any, of (a) the Company’s
consolidated assets (excluding goodwill, trademarks and other intangible assets) minus (b) the
Company’s consolidated liabilities, in each case as reported on the Company’s consolidated balance
sheet as of the Measurement Date, calculated in accordance with GAAP

5

 

consistently applied with prior periods: provided, however, that: (i) there
shall be included in Tangible Book Value, (A) the portion of the Premium, if any, not included in
the earnings of the Company for periods prior to the Measurement Date, multiplied by 57.954%, (B)
an add-back in an amount equal to the valuation allowance applied to the actual amount of deferred
tax assets as of the Measurement Date for Federal and California franchise tax purposes that may be
realized prior to the expiration of the applicable net operating loss carryforward periods;
provided that the amount of such add-back plus the amount of deferred tax assets for Federal and
California franchise tax purposes reflected on the consolidated balance sheet as of the Measurement
Date shall not exceed $150,000,000, (C) an add-back in an amount equal to any allowance for loan
losses specifically related to the A Participation Interest (as defined in the Asset Purchase
Agreement) as of the Measurement Date multiplied by 57.954%, and (D) the amount of any goodwill on
the consolidated balance sheet as of the Measurement Date related to acquisitions by the Company
that were approved by the Investor in writing and closed between the date of this Agreement and the
Measurement Date and (ii) there shall be excluded from Tangible Book Value, the effect of the
issuance of the Series A Preferred Stock and the Warrants. Tangible Book Value shall be determined
in good faith by the Board of Directors, subject to the approval of Investor, which approval will
not be unreasonably withheld.

          “Total Voting Power” means the total number of votes entitled to be cast by the
holders of the outstanding Common Stock and any other securities entitled, in the ordinary course,
to vote on matters put before the holders of the Common Stock generally.

          “Transfer” means, directly or indirectly, to sell , transfer, assign, pledge,
encumber, hypothecate or similarly dispose of (by operation of law or otherwise), either
voluntarily or involuntarily, or to enter into any contract, option or other arrangement or
understanding with respect to a sale, transfer, assignment, pledge, encumbrance, hypothecation or
similar disposition.

          “Underpayment Test” has the meaning assigned to it in Section 2(e)(12) hereof.

          “Warrants” mean the Original Warrant and the Additional Warrant.

          “Year-End Date” has the meaning assigned to it in the definition of Reset Date.

          All other capitalized terms used but not defined herein shall have the meanings given to such
terms in the Investment Agreement.

     2. Exchange, Put and Call.

          (a) Exchange at the Option of the Holder. Subject to and upon compliance with the provisions of this
Section 2, the holders of the shares of Series A Preferred Stock (the “Holders”) shall be entitled,
at their option, at any time and from time to time to exchange all or any such shares of Series A
Preferred Stock into newly issued, fully paid and non-assessable shares of Common Stock (determined
as provided below); provided that upon any call for redemption by the Bank pursuant to the
terms of the Series A Preferred Stock, the right to exchange shares so called for redemption shall
terminate at 5:00 p.m., New York City time, on the Business Day immediately preceding the
redemption date (unless the Bank defaults in paying the redemption price of the shares so called
for redemption). A Holder shall effect such

6

 

exchanges by delivering to the Company shares (or portions thereof) of Series A Preferred Stock
that the Holder is seeking to exchange, in exchange for which the Company shall issue to such
Holder (i) a number of shares of Common Stock equal to the quotient of (A) the Liquidation
Preference of the Series A Preferred Stock delivered for exchange divided by (B) the
Conversion Amount in effect at the close of business on the applicable Exchange Date; (ii) an
amount in cash equal to the amount of any declared but unpaid Base Dividends as of the applicable
Exchange Date on the shares of Series A Preferred Stock so exchanged, and (iii) an amount in cash
equal to the product of (A) the amount, if any, by which the Conversion Amount in effect at the
close of business on the applicable Exchange Date exceeds the Exchange Price in effect at the close
of business on the applicable Exchange Date multiplied by (B) the number of shares of
Common Stock issued upon such exchange. The “Conversion Amount” shall initially be $9.00 and shall
be adjusted in the same manner as the Exchange Price is adjusted pursuant to clauses (4), (6) and
(7) of Section 2(e).

          (b) Change of Control.

     (1) The Bank shall provide each Holder with written notice of a Change of Control (a
“Change of Control Notice”) at least thirty (30) days prior to such Change of
Control, or as soon as practicable thereafter. Each Holder shall have twenty (20) days
after receipt of such notice to request that the Company purchase the Series A Preferred
Stock then held by such Holder. Promptly, but in any event, within five (5) Business Days
of receipt of such request in writing, the Company shall purchase such Series A Preferred
Stock for cash at a purchase price equal to the Liquidation Preference for such shares plus
the amount of any declared but unpaid Base Dividends as of such date.

     (2) If any Holder does not exercise the its right to require the Company to purchase
its Series A Preferred Stock described in Section 2(b)(1) above within the 20-day period
specified therein, then upon written notice to such Holder within ten (10) days of the
expiration of such 20-day period, the Bank or the Company shall have the right to purchase
the Series A Preferred Stock then held by such Holder. Promptly, but in any event, within
five (5) Business Days of delivery of such notice to the Holder of the Company’s or Bank’s
election to exercise such purchase right, the Company or Bank, as applicable, shall purchase
such Series A Preferred Stock for cash at a purchase price equal to the Liquidation
Preference for such shares plus the amount of any declared but unpaid Base Dividends as of
such date. Notwithstanding anything in this Section 2(b)(2) to the contrary, the Holder
shall have the right to exchange its Series A Preferred Stock pursuant to Section 2(a)
hereof until 5:00 p.m., New York City time, on the Business Day immediately preceding the
purchase date.

     (3) If, upon the occurrence of a Change of Control (solely with respect to the Bank and
not the Company), a Holder has not exercised its right to require the Company to purchase
its Series A Preferred Stock pursuant to Section 2(b)(1) and neither the Company nor the
Bank has exercised its right to purchase such Holder’s Series A Preferred Stock pursuant to
Section (2)(b)(2) (or the Company and the Bank have determined not to exercise such right
prior to the expiration of such right), then each and every share of Series A Preferred
Stock held by such Holder shall be automatically exchanged into fully paid and
non-assessable shares of Common Stock (determined as

7

 

provided below) on a date selected by the Board of Directors not more than thirty (30)
days after the expiration of the purchase right set forth in Section 2(b)(2) above (the
“Automatic Exchange Date”). Upon such automatic exchange, upon the surrender to the
Company of its shares of Series A Preferred Stock, the Holder shall be entitled to receive
(i) a number of shares of Common Stock equal to the quotient of (A) the Liquidation
Preference of the Series A Preferred Stock held by such Holder divided by (B) the
Conversion Amount in effect at the close of business on the Automatic Exchange Date; (ii) an
amount in cash equal to the amount of any declared but unpaid Base Dividends as of the
Automatic Exchange Date on the shares of Series A Preferred Stock so exchanged, and (iii) an
amount in cash equal to the product of (A) the amount, if any, by which the Conversion
Amount in effect at the close of business on the Automatic Exchange Date exceeds the
Exchange Price in effect at the close of business on the Automatic Exchange Date
multiplied by (B) the number of shares of Common Stock issued upon such exchange.
In addition, in the event that the Current Market Price on the Automatic Exchange Date is
less than the Exchange Price in effect at the close of business on the Exchange Date, then
the Company shall pay to the Holder an amount in cash (together with the payments required
by clauses (ii) and (iii) of the immediately preceding sentence, the “Automatic Exchange
Payment”) equal to the product of (A) the difference between such Exchange Price and the
Current Market Price on the Automatic Exchange Date multiplied by (B) the number of shares
of Common Stock being issued to the Holder upon the exchange of the Holder’s Series A
Preferred Stock. If the Company does not have sufficient cash to make the Automatic
Exchange Payment or is legally or contractually prohibited from making such payment, the
Company shall pay such Automatic Exchange Payment (or any portion thereof, as applicable) in
a number of shares of Common Stock equal to the quotient of the portion of the Automatic
Exchange Payment that the Company is unable to pay divided by the Current
Market Price. On or before the 15th day prior to the Automatic Exchange Date,
the Company shall send written notice thereof to each Holder at its address then shown on
the records of the Bank, which notice shall state the circumstances constituting the Change
of Control and that certificates evidencing shares of Series A Preferred Stock must be
surrendered to the Company. Neither the failure to give any such notice nor any defect
therein shall affect the legality or validity of the procedures for the automatic exchange
of the Series A Preferred Stock.

          (c) Exchange Price. The exchange price (the “Exchange Price”) shall initially be $8.44 per
share of Series A Preferred Stock and, if the Shareholder Approval Date occurs prior to the Reset
Date, shall be increased to $9.00 per share of Series A Preferred Stock from (and including) and
after the Shareholder Approval Date, subject to adjustment from time to time in accordance with
Section 2(e).

          (d) Fractional Shares. Instead of any fractional share of Common Stock which would otherwise be
issuable upon exchange of any share of Series A Preferred Stock, the Company will pay a cash
adjustment in respect of such fractional share in an amount equal to the product of such fraction
multiplied by the Current Market Price of one share of Common Stock on the Exchange
Date or the Automatic Exchange Date, as the case may be. If more than one share of Series A
Preferred Stock shall be surrendered for exchange at one time by the same

8

 

Holder, the number of full shares of Common Stock to be issued shall be computed on the basis
of the aggregate number of shares of Series A Preferred Stock so surrendered.

          (e) Adjustments to Exchange Price and Exchange Features. The Exchange Price and exchange
features shall be subject to adjustment from time to time as follows:

     (1) Effective 5:00 P.M., New York time, on each of the Reset Date and, if it occurs on
or after the Reset Date, the Shareholder Approval Date, the Exchange Price shall be reset to
the lesser of (a) the Applicable Base Amount or (b) an amount equal to the quotient of: (i)
the product of (x) the Applicable Percentage multiplied by (y) the Tangible
Book Value as of the Measurement Date, divided by (ii) the Fully Diluted Outstanding Shares
as of the Measurement Date. If, prior to the Reset Date, an adjustment of the Exchange
Price has occurred pursuant to Section 2(e)(2), such adjustment(s) shall be made on the
reset Exchange Price determined by the immediately preceding sentence. If prior to the
Reset Date, any Holder shall have already exchanged any or all of its shares of Series A
Preferred Stock for shares of Common Stock, then the Company shall promptly pay to such
Holder, in respect of all the shares of Common Stock received upon each such exchange, an
amount in cash equal to the amount, if any, by which (A) the amount of cash that would be
payable to the Holder pursuant to Section 2(a)(iii) (giving effect to all prior Exchange
Price adjustments under this Section 2, but without giving effect to any adjustment payments
made pursuant to Section 2) if such Holder exchanged Series A Preferred Stock immediately
after the Reset Date having a Liquidation Preference equivalent to the shares of Series A
Preferred Stock delivered to the Company in connection with such exchange exceeds (B) the
amount by which the sum of payments made to such Holder in connection with the actual
exchange pursuant to Section 2(a)(iii), Section 2(e)(2) and Section 2(e)(3) exceeds any
amount paid by such Holder to the Company pursuant to Section 2(e)(12) with respect to such shares.
In the event that, prior to the Reset Date or, if it occurs on or after the Reset
Date, the Shareholder Approval Date, the Exchange Price shall have been adjusted pursuant to
clauses (4), (6) or (7) of this Section 2(e), then the Exchange Price shall be adjusted
pursuant to the first sentence of this clause (1) as if the event or events giving rise to
such adjustment(s) occurred immediately following the adjustment of the Exchange Price
pursuant to this clause (1).

     (2) If, on the date a final non-appealable judgment is rendered in the CDI Litigation
or a final binding settlement agreement is entered into by the Company and its relevant
subsidiaries with respect to the CDI Litigation (the “Litigation Resolution Date”),
the total costs incurred by the Company or its subsidiaries related to the CDI Litigation
after the Measurement Date (including, without limitation, judgments, fines and penalties
incurred in connection with the CDI Litigation, but excluding costs incurred in connection
with legal defense, consultant fees and any other third party costs incurred in connection
with the defense thereof) (the “Litigation Costs”) exceed $35,000,000 (such excess
being the “Litigation Cost Excess”), then the Exchange Price (after taking into
account the next sentence) shall be immediately adjusted downward by an amount equal to the
product of: (i) the Applicable Percentage then in effect multiplied by (ii) the
quotient of (A) the positive difference of the Litigation Cost Excess (net of any realizable
income tax benefits attributable to the Litigation Cost Excess) divided by (B) the
Fully

9

 

Diluted Outstanding Shares as of the Measurement Date. In the event that, prior to the
Litigation Resolution Date, the Exchange Price shall have been adjusted pursuant to clauses
(4), (6) or (7) of this Section 2(e), then the Exchange Price shall be adjusted pursuant to
the preceding sentence as if the event or events giving rise to such adjustment(s) occurred
immediately following the adjustment of the Exchange Price pursuant to this clause (2). If,
however, as of the Litigation Resolution Date, any Holder has already exchanged any or all
of its shares of Series A Preferred Stock for shares of Common Stock, then the Company shall
promptly pay to such Holder, in respect of all the shares of Common Stock received upon each
such exchange occurring prior to the Litigation Resolution Date, an amount in cash equal to
the amount, if any, by which (A) the amount of cash that would be payable to the Holder
pursuant to Section 2(a)(iii) (giving effect to all prior Exchange Price adjustments under
this Section 2, but without giving effect to any adjustment payments made pursuant to
Section 2) if such Holder exchanged Series A Preferred Stock immediately after the
Litigation Resolution Date having a Liquidation Preference equivalent to the shares of
Series A Preferred Stock delivered to the Company in connection with such exchange exceeds
(B) the amount by which the sum of payments made to such Holder in connection with the
actual exchange pursuant to Sections 2(a)(iii), Section 2(e)(1) and Section 2(e)(3)
exceeds any amount paid by such Holder to the Company pursuant to Section 2(e)(12)
with respect to such shares (such aggregate cash payment by the Company being referred to
herein as the “Litigation Settlement Amount”), provided, however,
that if the Company does not have sufficient cash to make such payment or is legally or
contractually prohibited from making such payment, the Company shall pay such Litigation
Settlement Amount (or any portion thereof) in a number of shares of Common Stock equal to
the quotient of the portion of the Litigation Settlement Amount that the Company is unable
to pay divided by the Current Market Price.

     (3) If, on June 30, 2010, the total cumulative losses (excluding losses attributable to
early payment defaults), liabilities or expenses incurred by the Company and its
Subsidiaries on a consolidated basis after the Measurement Date relating to the rights or
claims of third parties in connection with mortgage loans sold (whether as a whole loan
sale, securitization or otherwise) by the Company or any of its Subsidiaries prior to the
Measurement Date (the “Loan Losses”) exceed the sum of $35,000,000 plus a new
reserve established on the Company’s consolidated balance sheet at June 30, 2007 (excluding
any reserve for early payment defaults) (prepared in accordance with GAAP consistently
applied with prior periods) in connection with such loans (such excess being the “Loan
Loss Excess”), then the Exchange Price (after taking into account the next sentence)
shall be adjusted downward on such date by an amount equal to the product of: (i) the
Applicable Percentage then in effect multiplied by (ii) the quotient of (A) the Loan
Loss Excess (net of any realizable income tax benefits attributable to the Loan Loss Excess)
divided by (B) the Fully Diluted Outstanding Shares as of the Measurement Date. In
the event that, prior to June 30, 2010, the Exchange Price shall have been adjusted pursuant
to clauses (4), (6) or (7) of this Section 2(e), then the Exchange Price shall be adjusted
pursuant to the preceding sentence as if the event or events giving rise to such
adjustment(s) occurred immediately following the adjustment of the Exchange Price pursuant
to this clause (3). If, however, as of June 30, 2010, any Holder has already exchanged any
or all of its shares of Series A Preferred Stock for shares of Common

10

 

Stock, then the Company shall promptly pay to such Holder, in respect of all the shares
of Common Stock received upon each such exchange occurring prior to June 30, 2010, an amount
in cash equal to the amount, if any, by which (A) the amount of cash that would be payable
to the Holder pursuant to Section 2(a)(iii) (giving effect to all prior Exchange Price
adjustments under this Section 2, but without giving effect to any adjustment payments made
pursuant to Section 2) if such Holder exchanged Series A Preferred Stock immediately after
the June 30, 2010 having a Liquidation Preference equivalent to the shares of Series A
Preferred Stock delivered to the Company in connection with such exchange exceeds (B) the
amount by which the sum of payments made to such Holder in connection with the actual
exchange pursuant to Section 2(a)(iii), Section 2(e)(1) and Section 2(e)(2) exceeds any
amount paid by such Holder to the Company pursuant to Section 2(e)(12) with respect to such shares
(such aggregate cash payment by the Company being referred to herein as the “Loan
Loss Settlement Amount”), provided, however, that if the Company does
not have sufficient cash to make such payment or is legally or contractually prohibited from
making such payment, the Company shall pay such Loan Loss Settlement Amount (or any portion
thereof) in a number of shares of Common Stock equal to the quotient of the portion of the
Loan Loss Settlement Amount that the Company is unable to pay divided by the Current
Market Price.

     (4) Upon Issuance of Common Stock. If the Company shall, at any time or from
time to time after the Original Issue Date, issue any shares of Common Stock, options to
purchase or rights to subscribe for Common Stock, securities by their terms convertible into
or exchangeable for Common Stock, or options to purchase or rights to subscribe for such
convertible or exchangeable securities without consideration or for consideration per share
less than the Current Market Price, then each of the Exchange Price and the Conversion
Amount shall forthwith be lowered to a price equal to the price obtained by multiplying:

     (i) the Exchange Price or the Conversion Amount, as applicable, in
effect immediately prior to the issuance of such Common Stock, options,
rights or securities by

     (ii) a fraction of which (x) the numerator shall be the sum of (A)
the number of shares of Common Stock outstanding on a fully diluted basis
immediately prior to such issuance and (B) the number of additional shares
of Common Stock which the aggregate consideration for the number
of shares of Common Stock so offered would purchase at the Current Market
Price and (y) the denominator shall be the number of shares of Common
Stock outstanding on a fully diluted basis immediately after such
issuance.

The provisions of this clause (4) shall not apply to any issuance of Excluded Stock.

     (5) Provisions Applicable to Adjustments. For the purposes of any adjustment
of the Exchange Price or the Conversion Amount, as applicable, pursuant to Section 2(e)(4),
the following provisions shall be applicable:

11

 

     (i) In the case of the issuance of Common Stock for cash in a public
offering or private placement, the consideration shall be deemed to be
the amount of cash paid therefor before deducting therefrom any
discounts, commissions or placement fees payable by the Company to any
underwriter or placement agent in connection with the issuance and sale
thereof.

     (ii) In the case of the issuance of Common Stock for consideration
in whole or in part other than cash, the consideration other than cash
shall be deemed to be the Fair Market Value thereof.

     (iii) In the case of the issuance of options to purchase or rights
to subscribe for Common Stock, securities by their terms convertible into
or exchangeable for Common Stock, or options to purchase or rights to
subscribe for such convertible or exchangeable securities (except for
options to acquire or rights to subscribe for, or securities convertible
into or exchangeable for, Excluded Stock):

     a) the aggregate maximum number of shares of Common Stock deliverable
upon exercise of any such options to purchase or rights to subscribe for
Common Stock shall be deemed to have been issued at the time such options or
rights were issued and for a consideration equal to the consideration
(determined in the manner provided in subparagraphs (i) and (ii) of this
clause (5)), if any, received by the Company upon the issuance of such
options or rights plus the minimum purchase price provided in such options
or rights for the Common Stock covered thereby;

     b) the aggregate maximum number of shares of Common Stock deliverable
upon conversion of or in exchange for any such convertible or exchangeable
securities or upon the exercise of options to purchase or rights to
subscribe for such convertible or exchangeable securities and subsequent
conversion or exchange thereof shall be deemed to have been issued at the
time such securities, options, or rights were issued and for a consideration
equal to the consideration received by the Company for any such securities
and related options or rights, plus the additional consideration, if any, to
be received by the Company upon the conversion or exchange of such
securities or the exercise of any related options or rights (the
consideration in each case to be determined in the manner provided in
paragraphs (i) and (ii) of this clause (5));

     c) on any change in the number of shares or exercise price of Common
Stock deliverable upon exercise of any such options or rights or conversions
of or exchanges for such securities, other than a change resulting from the
anti-dilution provisions thereof, the Exchange Price or Conversion Amount,
as applicable shall forthwith be readjusted to such Exchange Price or
Conversion Amount, as applicable, as would have been obtained had the
adjustment made upon the issuance of such options,

12

 

rights or securities not converted prior to such change or options or
rights related to such securities not converted prior to such change been
made upon the basis of such change;

     d) upon the expiration of any options to purchase or rights to
subscribe for Common Stock which shall not have been exercised, the Exchange
Price or Conversion Amount, as applicable, computed upon the original issue
thereof (or upon the occurrence of a record date with respect thereto), and
any subsequent adjustments based thereon, shall, upon such expiration, be
recomputed as if the only additional shares of Common Stock issued were the shares
of Common Stock, if any, actually issued upon the exercise of such
options to purchase or rights to subscribe for Common Stock, and the
consideration received therefor was the consideration actually received by
the Company for the issue of the options to purchase or rights to subscribe
for Common Stock that were exercised, plus the consideration actually
received by the Company upon such exercise; and

     e) no further adjustment of the Exchange Price or Conversion Amount, as
applicable, adjusted upon the issuance of any such options, rights,
convertible securities or exchangeable securities shall be made as a result
of the actual issuance of Common Stock on the exercise of any such rights or
options or any conversion or exchange of any such securities.

     (6) Upon Stock Dividends, Subdivisions or Splits. If, at any time after the Original Issue Date, the number of shares of Common Stock
outstanding is increased by a stock dividend payable in shares of Common Stock or by a
subdivision or split up of shares of Common Stock, then, following the record date for the
determination of holders of Common Stock entitled to receive such stock dividend, or to be
affected by such subdivision or split up, each of the Exchange Price and the Conversion
Amount shall be appropriately decreased to equal the product of the Exchange Price or the
Conversion Amount, as applicable, multiplied by a fraction, the numerator of which
is the number of shares of Common Stock outstanding immediately prior to such increase and
the denominator of which is the number of shares of Common Stock outstanding immediately
after such increase.

     (7) Upon Combinations or Reverse Stock Splits. If, at any time after the
Original Issue Date, the number of shares of Common Stock outstanding is decreased by a
combination or reverse stock split of the outstanding shares of Common Stock into a smaller
number of shares of Common Stock, then, following the record date to determine shares
affected by such combination or reverse stock split, each of the Exchange Price and the
Conversion Amount shall be appropriately increased to equal the product of the Exchange
Price or the Conversion Amount, as applicable, multiplied by a fraction, the numerator of
which is the number of shares of Common Stock outstanding immediately prior to such decrease
and the denominator of which is the number of shares of Common Stock outstanding immediately
after such decrease in outstanding shares.

13

 

     (8) Upon Reclassifications, Reorganizations, Consolidations or Mergers. In the event of any capital reorganization of the Company, any reclassification of
the stock of the Company (other than a change in par value or from par value to no par value
or from no par value to par value or as a result of a stock dividend or subdivision, split
up or combination of shares), or any consolidation or merger of the Company with or into
another Person (where the Company is not the surviving Person or where there is a change in
or distribution with respect to the Common Stock), each share of Series A Preferred Stock
shall after such reorganization, reclassification, consolidation, or merger be exchangeable
for the kind and number of shares of stock or other securities or property of the Company or
of the successor Person resulting from such consolidation or surviving such merger, if any,
to which the holder of the number of shares of Common Stock deliverable (immediately prior
to the time of such reorganization, reclassification, consolidation or merger) upon exchange
of such share of Series A Preferred Stock would have been entitled upon such reorganization,
reclassification, consolidation or merger. The provisions of this clause shall similarly
apply to successive reorganizations, reclassifications, consolidations, or mergers. The
Company shall not effect any such reorganization, reclassification, consolidation or merger
unless, prior to the consummation thereof, the successor Person (if other than the Company)
resulting from such reorganization, reclassification, consolidation or merger, shall assume,
by written instrument, the obligation to deliver to the holder such shares of stock,
securities or assets, which, in accordance with the foregoing provisions, such holder shall
be entitled to receive upon such exchange.

     (9) Deferral in Certain Circumstances. In any case in which the provisions of
this Section 2(e) shall require that an adjustment shall become effective immediately after
a record date of an event, the Company may defer until the occurrence of such event (i)
issuing to the Holder with respect to any share of Series A Preferred Stock exchanged after
such record date and before the occurrence of such event the shares of Common Stock issuable
or cash payable upon such exchange by reason of the adjustment required by such event and
issuing to such Holder only the shares of Common Stock issuable upon such exchange before
giving effect to such adjustments, and (ii) paying to such Holder any amount in cash in lieu
of a fractional share of Common Stock pursuant to Section 2(d); provided that the
Company shall deliver to such Holder an appropriate instrument or due bills evidencing such
Holder’s right to receive such additional shares or such cash.

     (10) Adjustment of Number of Shares Issuable Upon Exchange. Upon any
adjustment of the Conversion Amount as provided in clauses (4), (6) or (7), Holders of shares
of Series A Preferred Stock shall thereafter be entitled to receive upon the exchange
thereof, at the Conversion Amount resulting from such adjustment, the number of shares of
Common Stock (calculated to the nearest 1/100th of a share) obtained by multiplying the
Conversion Amount in effect immediately prior to such adjustment by the number of shares of
Common Stock issuable on the exchange of such Series A Preferred Stock immediately prior to
such adjustment and dividing the product thereof by the Conversion Amount resulting from
such adjustment.

     (11) Exceptions. Section 2(e) shall not apply to any shares of Common Stock
(i) issued as consideration when any corporation or business is acquired, merged into, or

14

 

becomes part of the Company or a subsidiary of the Company, (ii) issued upon exercise of any
options, warrants or other rights assumed by the Company in connection with a merger or
other acquisition; provided that such options, warrants or other rights assumed by
the Company shall not have been issued in connection with or in contemplation of such merger
or acquisition, (iii) issued in good faith in connection with any other acquisition of
assets in an arms-length transaction between the Company and an unaffiliated third party,
(iv) issued upon exercise of the Warrant, (v) issued to employees or directors of the
Company pursuant to an employee stock option plan or stock incentive plan approved by the
Board of Directors at no less than market value on the date of grant, or (vi) issued to
officers and employees pursuant to employment agreements in existence on the date hereof at
no less than market value on the date of issuance (collectively, the “Excluded
Stock”). Additionally, no further adjustments to the Exchange Price shall be made under
Sections 2(e)(2) or Section 2(e)(3) from and after the date the Permitted Holders cease to
beneficially own and/or have the right to acquire at least 5% of the Aggregate Initial
Shares.

     (12) Shareholder Approval Date Adjustment. If, prior to the Shareholder
Approval Date, any shares of Series A Preferred Stock have been exchanged for Common Stock
pursuant to the terms hereof, then, within five Business Days after the Shareholder Approval
Date, each Holder shall repay to the Company a portion of the cash received from the Company
in such exchanges, and pursuant to the adjustments contained in Sections 2(e)(1), 2(e)(2)
and 2(e)(3), such that the net amount of cash retained by such Holder (and its predecessors)
from such exchanges and adjustments equals the aggregate amount of cash the Company would
have been obligated to pay in such exchanges and adjustments if the Shareholder Approval had
occurred prior to such exchanges and adjustments (the “Underpayment Test”). If the
Underpayment Test is satisfied without a payment by the Holder to the Company, then the
Holder shall not be required to pay any amount under this Section 2(e)(12).

          (f) Exchange Mechanics.

     (1) To exchange shares of Series A Preferred Stock pursuant to Section 2(a), a Holder
must (i) deliver to the Company a duly completed notice (the “Exchange Notice”) in
the form attached hereto as Exhibit A, (ii) surrender the certificate or
certificates evidencing such Holder’s shares of Series A Preferred Stock to be exchanged,
together with duly executed stock powers endorsed to the Company or such other assignments
or instruments of conveyance and transfer, in form and substance satisfactory to the
Company, as shall be effective to vest in the Company all right, title and interest in and
to the Series A Preferred Stock, and (iii) if required, pay any transfer or similar tax in
accordance with Section 2(i). Shares of Series A Preferred Stock exchanged pursuant to
Section 2(b) will be exchanged on the Automatic Exchange Date.

     (2) Except in the case of an exchange pursuant to Section 2(b), Series A Preferred
Stock shall be deemed to have been exchanged immediately prior to the close of business on
the day of surrender of such shares of Series A Preferred Stock for
exchange (together with duly executed stock powers or such other assignments or
instruments required by the Company) in accordance with the foregoing provisions and

15

 

delivery of the Exchange Notice to the Company (the “Exchange Date”). In the case
of an exchange pursuant to Section 2(b), such exchange shall occur automatically on the
Automatic Exchange Date and without any further action by the Holders of such shares and
whether or not the certificates representing such shares are surrendered to the Company.
From and after the Exchange Date or the Automatic Exchange Date, as the case may be,
dividends on the shares of Series A Preferred Stock so exchanged shall cease to accrue to
the exchanging Holders, and all rights of such Holders as shareholders of the Bank shall
cease. The Person or Persons entitled to receive the Common Stock issuable upon exchange
shall be treated for all purposes as the record holder or holders of such Common Stock as
and after such time.

     (3) As promptly as practicable on or after the Exchange Date or the Automatic Exchange
Date, as the case may be, the Company shall issue and shall deliver a certificate or
certificates for the number of full shares of Common Stock issuable upon exchange, together
with (i) the aggregate amount of cash payable pursuant to Section 2(a), (ii) any applicable
Automatic Exchange Payment and (iii) payment in lieu of any fractional shares as provided in
Section 2(d); provided that, in the case of an automatic exchange pursuant to
Section 2(b), the Company shall not be obligated to issue certificates evidencing the shares
of Common Stock issuable upon such exchange or any applicable Automatic Exchange Payment
unless certificates evidencing such shares of Series A Preferred Stock so exchanged are
surrendered to the Company.

     (4) In the case of any certificate evidencing shares of Series A Preferred Stock which
is exchanged in part only, upon such exchange the Bank shall execute and deliver a new
certificate representing an aggregate number of shares of Series A Preferred Stock equal to
the unexchanged portion of such certificate.

          (g) Notice of Adjustment of Exchange Price. Whenever the Exchange Price or Conversion
Amount, as applicable, is adjusted as herein provided (i) the Company shall compute the adjusted
Exchange Price or Conversion Amount, as applicable, in accordance with Section 2(e) and shall
prepare a certificate signed by the Treasurer or Chief Financial Officer of the Company setting
forth the adjusted Exchange Price or Conversion Amount, as applicable, and showing in reasonable
detail the facts upon which such adjustment is based, and such certificate shall forthwith be
filed at each office or agency maintained for such purpose or exchange of shares of Series A
Preferred Stock, and (ii) a notice stating that the Exchange Price or the Conversion Amount, as
applicable, has been adjusted and setting forth the adjusted Exchange Price or the Conversion
Amount, as applicable, shall forthwith be prepared by the Company, and as soon as practicable
after it is prepared, such notice shall be mailed by the Company at its expense to each holder of
record of Series A Preferred Stock at his or its address then shown on the records of the Bank.

          (h) Company
to Reserve Common Stock. The Company shall at all times reserve and keep
available, free from preemptive rights, out of the authorized but unissued Common Stock or out of
the Common Stock held in treasury, for the purpose of effecting the exchange of Series A Preferred
Stock, the full number of shares of Common Stock then issuable
upon the exchange of all outstanding shares of Series A Preferred Stock and the exercise of
all outstanding Warrants. Before taking any action that would cause an adjustment reducing the

16

 

Conversion Amount below the then par value (if any) of the shares of Common Stock deliverable upon
exchange of the Series A Preferred Stock or that would cause the number of shares of Common Stock
deliverable upon exchange of the Series A Preferred Stock to exceed (when taken together with all
other outstanding shares of Common Stock) the number of shares of Common Stock that the Company is
authorized to issue, the Company will take any corporate action that, in the opinion of its
counsel, is necessary in order that the Company may validly and legally issue the full number of
fully paid and non-assessable shares of Common Stock issuable upon exchange at such adjusted
Conversion Amount.

          (i) Taxes on Exchange. The Company will pay any and all original issuance, transfer, stamp
and other similar taxes that may be payable in respect of the issue or delivery of shares of
Common Stock on exchange of Series A Preferred Stock pursuant hereto. The Company shall not,
however, be required to pay any tax which may be payable in respect of any transfer involved in
the issue and delivery of shares of Common Stock in a name other than that of the Holder of the
share(s) of Series A Preferred Stock to be exchanged, and no such issue or delivery shall be made
unless and until the Person requesting such issue has paid to the Company the amount of any such
tax, or has established to the reasonable satisfaction of the Company that such tax has been or
will be paid.

          (j) Compliance with Law. All issuances of Common Stock pursuant to this Agreement shall be
subject to compliance with all legal and bank regulatory requirements.

     3. Governance.

          (a) Composition of the Board of Directors.

     (1) The Company will cause Gerald J. Ford and Carl B. Webb (each, an “Initial
Investor Nominee” and, collectively, the “Initial Investor Nominees”) to be
elected or appointed to the board of directors of each of the Company and the Bank
concurrently with the Closing. The board of directors of each of the Company and the Bank
shall elect Mr. Ford to the position of Chairman concurrently with his election or
appointment.

     (2) Subject to Sections 3(a)(4) and 3(a)(5) below:

     (i) the Company’s Governance and Nominating Committee (or any other
committee exercising a similar function) shall recommend to the Company’s
board of directors that the Initial Investor Nominees (or any successors
designated by the Investor in accordance with Section 3(a)(3) below) be
included in the slate of nominees recommended by the board of directors
of the Company to the Company’s shareholders for election as directors at
each annual meeting of shareholders of the Company at which each such
Initial Investor Nominee’s term expires; and

     (ii) the Company and the Bank shall cause the Initial Investor
Nominees (or any successors designated by the Investor in accordance

17

 

with Section 3(a)(3) below) to be members of the Bank’s board of directors at
all times.

     (3) Subject to Sections 3(a)(4) and 3(a)(5) below, if any Initial Investor Nominee
shall cease to serve as a director for any reason, the board of directors of each of the
Company and the Bank will use its reasonable best efforts to take all action required to
fill the vacancy resulting therefrom with a person designated solely by the Investor.

     (4) At such time as the Investor and/or its Affiliates shall have transferred such
number of the Aggregate Initial Shares, whether received upon exchange of the Series A
Preferred Stock or upon exercise of the Warrants (other than to Affiliates of the Investor),
that in the aggregate represent in excess of 50%, but not greater than 75%, of the number of
Aggregate Initial Shares, then the Investor shall have the right to designate only one
member to serve on the respective boards of directors of the Company and the Bank.

     (5) At such time as the Investor and/or its Affiliates shall have transferred such
number of Aggregate Initial Shares, whether received upon exchange of the Series A Preferred
Stock or upon exercise of the Warrants (other than to Affiliates of the Investor ), that in
the aggregate represent in excess of 75% of the number of Aggregate Initial Shares, then the
Investor shall have no further rights under Sections 3(a)(1) through 3(a)(3).

     (6) If the Bank shall fail to pay dividends as provided in Section 1(b) of the
Certificate of Determination, then the Holders shall be entitled to elect up to two special
directors (each, an “Additional Holder Nominee” and together with the Initial
Investor Nominees, “Investor Nominees”) to the board of directors of the Company (in
addition to the then authorized number of directors), and at each succeeding annual meeting
of shareholders of the Company thereafter until such right is terminated as herein provided;
provided, however, that if at such time, there shall be any Initial Investor
Nominees (or any successor of an Initial Investor Nominee appointed to the board of
directors in accordance with Section 3(a)(3) herein) serving on the board of directors of
the Company, then the number of Additional Holder Nominees shall be reduced by the number of
Initial Investor Nominees (or any successor of an Initial Investor Nominee appointed to the
board of directors in accordance with Section 3(a)(3) herein) then serving on the board of
directors of the Company.

          (b) Company Officers.

     (1) At or prior to the Closing, Carl B. Webb shall be appointed the President and Chief
Executive Officer of both the Company and the Bank, and J. Randy Staff shall be appointed
the Chief Financial Officer of both the Company and the Bank.

     4. Transfer Restrictions and Restricted Payments.

          (a) Transfers to Permitted Holders. Notwithstanding any provision in this Section 4 to the
contrary, on or before the first anniversary of the date hereof, the Investor or any

18

 

of its
Affiliates shall be permitted to Transfer any portion of the Warrants, the Series A Preferred
Stock or shares of Common Stock issuable upon exercise or exchange thereof, to an Affiliate or
another Permitted Holder; provided, however, that, except as provided by Section
2(b), at all times between the Closing and the second anniversary thereof, the Investor and its
Affiliates shall hold not less than 40% of the Series A Preferred Stock issued pursuant to the
Investment Agreement (or the Common Stock issuable upon exchange thereof).

          (b) Warrant. Following the Closing, the Investor shall not be permitted to Transfer a
Warrant other than to an Affiliate of the Investor, another Permitted Holder or to an Affiliate of
a Permitted Holder that agrees in writing with the Company to be bound by this Agreement as fully
as if it were an initial signatory hereto.

          (c) Series A Preferred Stock.

     (1) From and after the Closing until the second anniversary thereof, the Investor shall
not be permitted to Transfer any of the Series A Preferred Stock other than to an Affiliate
of the Investor, another Permitted Holder or to an Affiliate of a Permitted Holder that
agrees in writing with the Company and the Bank to be bound by this Agreement as fully as if
it were an initial signatory hereto; provided, however, that, except as
provided by Section 2(b), at all times between the Closing and the second anniversary
thereof, the Investor and its Affiliates shall hold not less than 40% of the Series A
Preferred Stock issued pursuant to the Investment Agreement (or the Common Stock issuable
upon exchange thereof).

     (2) From and after the second anniversary of the Closing, the Investor shall not, nor
shall it permit its Affiliates to, Transfer or agree to Transfer any of the Series A
Preferred Stock; provided that the foregoing restriction shall not be applicable to
Transfers to (y) an Affiliate of the Investor, another Permitted Holder or to an Affiliate
of a Permitted Holder that agrees in writing with the Company and the Bank to be bound by
this Agreement as fully as if it were an initial signatory hereto and (z) any Person if the
number of shares of Series A Preferred Stock Transferred to such Person are exchangeable for
shares of Common Stock representing less than 5% of the Total Voting Power, subject to the
satisfaction of each of the following conditions:

     (i) The Investor or its Affiliate thereof proposing to Transfer the
Series A Preferred Stock shall give written notice of the proposed
Transfer to the Bank, which notice shall state the identity and address
of the proposed transferee and the number of Series A Preferred Stock to
be Transferred.

     (ii) Any Transfer of Series A Preferred Stock shall be made only to
a Qualified Transferee; provided, however, that, for such
purposes, all Qualified Transferees that are Affiliates of each other, or
that comprise investment accounts or funds managed by a single
Qualified Transferee and its Affiliates, shall be considered
together to be a single Qualified Transferee.

19

 

     (iii) The Investor or the Affiliate thereof proposing the Transfer
of the Series A Preferred Stock shall deliver or cause to be delivered to
the Company an opinion of counsel reasonably satisfactory to the Company
to the effect that the proposed Transfer may be effected without
registration under the Securities Act and will not otherwise violate the
registration provisions of the Securities Act or violate any state
securities laws or regulations applicable to the Bank or the Series A
Preferred Stock; provided, however, that the Company may,
in its sole discretion, waive this condition upon the request of the
Investor or the Affiliate thereof, as applicable. If, in the opinion of
the Company’s counsel, such Transfer would require the filing of a
registration statement under the Securities Act or would otherwise
violate any Federal or state securities laws applicable to the Bank or
the Series A Preferred Stock, the Company may prohibit any Transfer
otherwise permitted under this Section 4(c).

     (iv) Any transferee of the Series A Preferred Stock must agree in
writing with the Company and the Bank to be bound by the this Agreement
as fully as if it were an initial signatory hereto and thereto.

          (d) Common Stock.

     (1) From and after the Closing until the second anniversary thereof, (A) the Investor
shall not be permitted to Transfer any shares of Common Stock acquired upon exercise of a
Warrant other than to an Affiliate of the Investor, a Permitted Holder or to an Affiliate of
a Permitted Holder that agrees in writing with the Company and the Bank to be bound by this
Agreement as fully as if it were an initial signatory hereto and (B) the Investor shall not
be permitted to Transfer any shares of Common Stock acquired upon exchange of the Series A
Preferred Stock other than to an Affiliate of the Investor that agrees in writing with the
Company and the Bank to be bound by this Agreement as fully as if it were an initial
signatory hereto.

     (2) From and after the second anniversary of the Closing, the Investor shall not, nor
shall it permit its Affiliates to, Transfer or agree to Transfer any shares of the Company’s
Common Stock acquired upon exercise or exchange of a Warrant or the Series A Preferred
Stock, as applicable; provided that the foregoing restriction shall not be
applicable to Transfers:

     (i) to an Affiliate of the Investor, another Permitted Holder or to
an Affiliate of a Permitted Holder that agrees in writing with the
Company and the Bank to be bound by this Agreement as fully as if it were
an initial signatory hereto;

     (ii) in accordance with Rule 144 under the Securities Act applicable
to sales of securities by Affiliates of an issuer (regardless of whether
the Investor is deemed at such time to be an Affiliate of the Company);

20

 

     (iii) pursuant to a privately negotiated transaction, to any Person
if the number of shares Transferred to such person represents less than
5% of the Total Voting Power;

     (iv) pursuant to a distribution to the public, registered under the
Securities Act, in which the Investor uses its reasonable best efforts to
(A) effect as wide a distribution of such shares as is reasonably
practicable, and (B) not sell such shares to any Person (excluding
underwriters of such proposed distribution) if the number of shares
Transferred to such person would represent more than 5% of the Total
Voting Power; or

     (v) in connection with a merger, consolidation, reorganization,
recapitalization, tender offer, exchange offer or other similar
transaction.

     (3) The restrictions set forth in this Section 4 shall not apply to any Transfer by the
Investor or an Affiliate of the Investor by gift or sale, pursuant to a marital
dissolution’s division of assets, or upon death or permanent incapacity to a guardian,
conservator, executor, administrator, trustees or beneficiaries of its will, spouse,
children, stepchildren, grandchildren, parents, siblings or legal dependents, to a trust of
which the beneficiary or beneficiaries of the corpus and the income shall be such a Person
or Persons or the shareholder provided that such transferee agrees to be bound by this
Agreement as fully as if it were an initial signatory hereto.

     (4) Any attempted Transfer in violation of this Agreement shall be of no effect and
null and void, regardless of whether the purported transferee has any actual or constructive
knowledge of the Transfer restrictions set forth herein, and shall not be recorded on the
stock transfer books of the Company or the Bank, as applicable.

     (5) The Investor agrees that it will not evade the restrictions on Transfer set forth
in this Section 4 by Transferring any portion of the Warrants, the Series A Preferred Stock
or shares of Common Stock issuable upon exercise or exchange thereof to an Affiliate and
thereafter Transferring Beneficial Ownership of such Affiliate.

     (e) Legend on Securities. Each certificate representing shares of Common Stock Beneficially Owned by the
Investor or its Affiliates and subject to the terms of this Agreement shall bear the
following legend on the face thereof:

     “THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFER AND CERTAIN OTHER
LIMITATIONS SET FORTH IN A CERTAIN EXCHANGE AND SHAREHOLDER RIGHTS AGREEMENT DATED
AS OF      , 2007, AMONG FREMONT GENERAL CORPORATION (THE “COMPANY”), FREMONT
INVESTMENT & LOAN (THE “BANK”) AND HUNTER’S GLEN/FORD, LTD., AS THE SAME MAY BE
AMENDED FROM TIME TO TIME (THE

21

 

“AGREEMENT”), COPIES OF WHICH AGREEMENT ARE ON FILE
AT THE PRINCIPAL OFFICE OF THE COMPANY.”

     (2) Each certificate representing Series A Preferred Stock shall bear the following
legend on the face thereof:

     “THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFER AND CERTAIN OTHER LIMITATIONS SET FORTH IN A CERTAIN EXCHANGE AND
SHAREHOLDER RIGHTS AGREEMENT DATED AS OF      , 2007, AMONG FREMONT GENERAL
CORPORATION (THE “COMPANY”), FREMONT INVESTMENT & LOAN (THE “BANK”) AND HUNTER’S
GLEN/FORD, LTD., AS THE SAME MAY BE AMENDED FROM TIME TO TIME (THE “AGREEMENT”),
COPIES OF WHICH AGREEMENT ARE ON FILE AT THE PRINCIPAL OFFICE OF THE BANK.”

     (3) The Company may make a notation on its records or give instructions to any transfer
agents or registrars for Common Stock in order to implement the restrictions on Transfer set
forth in this Agreement.

          (f) Restrictions on Redemptions, Dividends and Distributions.

     (1) The Company agrees, from and after the Closing Date that it will not redeem, retire
or repurchase any shares of Common Stock prior to the exchange or redemption of the Series A
Preferred Stock. Additionally, the Company agrees that it will provide thirty (30) days
prior written notice to the Investor or any Affiliate thereof prior to any proposed
redemption, retirement or repurchase. The Bank agrees, from and after the Closing Date that
it will not redeem, retire or repurchase any shares of its common stock prior to the
exchange or redemption of the Series A Preferred Stock. Additionally, the Bank agrees that
it will provide thirty (30) days prior written notice to the Investor or any Affiliate
thereof prior to any proposed redemption, retirement or repurchase.

     (2) Without the unanimous consent of the entire Board of Directors, the Company shall
not pay any dividend or distribution on its outstanding shares of Common Stock in any year
in an amount that, when added to all prior dividends and distributions paid on Common Stock
in such year, exceeds the quotient of the total dividends or distributions paid with respect
to the Series A Preferred Stock outstanding during such year divided by the weighted daily
average number of shares into which the Series A Preferred Stock could have been exchanged
during such year.

          (g) Standstill. From the date of this Agreement until such time following the Closing as the
Investor Beneficially Owns shares of the Company’s capital stock representing less than 5% of the
Total Voting Power, the Investor covenants and agrees with the Company that it will not, nor will
it permit any of its Affiliates to, directly or indirectly, acquire, including by joining a
partnership, syndicate or other Group or otherwise, any shares of the Company’s capital stock if
such acquisition would result in the Investor Beneficially Owning shares of the

22

 

Company’s capital
stock representing more than 39.9% of the Total Voting Power. Notwithstanding anything herein to
the contrary, the Company agrees that the prohibitions of the preceding sentence shall not apply
to any Affiliate of a Permitted Holder that is engaged in the business of trading in
publicly-traded securities as part of ordinary course broker-dealer activities, so long as such
Affiliates have not received, or been given access to, any of the internal information or files of
the Company and have not received any instructions, recommendations or advice pertaining to an
investment in or control of the Company from any party having access to any material non-public
information regarding the Company.

     5. Miscellaneous.

          (a) Fees and Expenses. Each party shall bear its own expenses, including the fees and
expenses of any Representatives engaged by it, incurred in connection with this Agreement and the
transactions contemplated hereby and thereby.

          (b) Notices. All notices and other communications hereunder shall be in writing and shall be
deemed to have been duly given, if delivered personally, by telecopier or sent by first class
mail, postage prepaid, as follows:

23

 

If to the Company or the Bank, to:

Fremont General Corporation

2425 Olympic Boulevard, Third Floor

Santa Monica, California 90404

Attention: General Counsel

Fax: (310) 315-5593

With a copy to:

Skadden, Arps, Slate, Meagher & Flom LLP

Four Times Square

New York, New York 10036

Attention: William S. Rubenstein, Esq.

Fax: (917) 777-2642

If to the Investor, to:

Hunter’s Glen/Ford, Ltd.

200 Crescent Court, Suite 1350

Dallas, Texas 75201

Attention: J. Randy Staff

Fax: (214) 871-5122

With a copy to:

Gibson, Dunn & Crutcher LLP

333 South Grand Avenue

Los Angeles, CA 90071

Attention: Dhiya El-Saden, Esq.

Fax: (213) 229-6196

If to any other Holder, to such address for such Holder set forth
in the books and records of the Company and Bank, or to such other
address or to the attention of such other Person as the Holder has
specified by written notice to the Company.

          (c) Entire Agreement. This Agreement sets forth the entire agreement between the parties
hereto with respect to the subject matter hereof and supersedes and replaces all other prior
agreements, written or oral, among the parties hereto with respect to the subject matter hereof.

          (d) Amendments. The provisions of this Agreement, including the provisions of this sentence,
may not be amended, modified or supplemented, and waivers or consents to departures from the
provisions hereof may not be given without the prior written consent of the Holders of a majority
of the Series A Preferred Stock (as constituted on the date hereof); provided that without
a Holder’s written consent no such amendment, modification, supplement or waiver shall affect
adversely such Holder’s rights hereunder in a discriminatory manner

24

 

inconsistent with its adverse effects on rights of other Holders hereunder (other than as
reflected by the different number of shares held by such Holder); provided further
that the consent or agreement of the Company shall be required with regard to any termination,
amendment, modification or supplement of, or waivers or consents to departures from, the terms
hereof, which affect the Company’s obligations hereunder. This Agreement cannot be changed,
modified, discharged or terminated by oral agreement.

          (e) Counterparts. This Agreement may be executed in two or more counterparts, each of which
shall be deemed to constitute an original, but all of which together shall constitute one and the
same document. This Agreement may be executed by facsimile signature and a facsimile signature
shall constitute an original for all purposes.

          (f) Governing Law. This Agreement shall be governed by, and interpreted, in accordance with,
the laws of the State of New York applicable to contracts made and to be performed in that state.

          (g) Successors and Assigns. The Investor’s rights pursuant to Section 3 hereof shall be
non-assignable, except to an Affiliate of Investor. Subject to the foregoing, each Holder of
Series A Preferred Stock shall be permitted to assign its rights in connection therewith in
connection with Transfers of Series A Preferred Stock permitted by Section 4 hereof. Subject to
the foregoing, the provisions hereof shall inure to the benefit of, and be binding upon, the
parties hereto and their respective successors and assigns.

          (h) Remedies; Waiver. To the extent permitted by Law, all rights and remedies existing under
this Agreement and any related agreements or documents are cumulative to, and are exclusive of,
any rights or remedies otherwise available under applicable Law. No failure on the part of any
party to exercise, or delay in exercising, any right hereunder shall be deemed a waiver thereof,
nor shall any single or partial exercise preclude any further or other exercise of such or any
other right.

          (i) Specific Performance; Consent to Jurisdiction. Each party hereto acknowledges that, in
view of the uniqueness of the transactions contemplated by this Agreement, the other parties would
not have an adequate remedy at law for money damages in the event that this Agreement has not been
performed in accordance with its terms. Each party therefore agrees that the other parties shall
be entitled to specific enforcement of the terms hereof in addition to any other remedy to which
they may be entitled, at law or in equity, in any Federal court located in the State of California
or in any state court in the State of California. In addition, each of the parties hereto (i)
consents to submit itself to the personal jurisdiction of any Federal or state court located in
the State of California in the event any dispute arises out of this Agreement or the transactions
contemplated hereby, (ii) agrees that it will not attempt to deny or defeat such personal
jurisdiction by motion or other request for leave from any such court and (iii) agrees that it
will not bring any action relating to this Agreement or the transactions contemplated hereby in
any court other than a Federal or state court located in the State of California.

          (j) Severability. If any provision of this Agreement is determined to be invalid, illegal,
or unenforceable, the remaining provisions of this Agreement shall remain in
full force and effect provided that the economic and legal substance of the transactions
contemplated

25

 

is not affected in any manner materially adverse to any party. In the event of any
such determination, the parties agree to negotiate in good faith to modify this Agreement to
fulfill as closely as possible the original intent and purpose hereof. To the extent permitted by
law, the parties hereby to the same extent waive any provision of law that renders any provision
hereof prohibited or unenforceable in any respect.

          (k) Survival. The parties agree that the provisions of this Agreement shall survive the
exchange of the Series A Preferred Stock pursuant to the terms herein.

          (l) Joinder Agreements. Notwithstanding anything else contained herein, when this Agreement
requires that any transferee or Permitted Holder agree in writing with the Company and the Bank to
be bound by this Agreement as fully as if it were an initial signatory hereto, such transferee or
Permitted Holder shall not have any of the rights of the Investor set forth in Section 3 hereof.

[Signature Page Follows]

26

 

     IN WITNESS WHEREOF, this Exchange and Shareholder Rights Agreement has been duly executed by
each of the parties hereto as of the date first written above.

	 	 	 	 	 
	 	FREMONT GENERAL CORPORATION

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	FREMONT INVESTMENT & LOAN

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	Confirmed and accepted as of the date first written above:

HUNTER’S GLEN/FORD, LTD.

 	 	 
	By:  	 	 	 
	 	Name:  	 	 	 
	 	Title:  	 	 	 
	 

Exchange Rights Agreement Signature Page

 

 

EXHIBIT A

EXCHANGE NOTICE

     The undersigned, being a holder of the 6.5% Series A Non-Cumulative Exchangeable Preferred
Stock of Fremont Investment & Loan (the “Series A Preferred Stock”) irrevocably exercises
the right to exchange                      outstanding shares of Series A Preferred Stock on                     ,
     , for shares of common stock, par value $1.00 per share (the “Common Stock”) of Fremont
General Corporation in accordance with the terms hereof, and directs that the shares of Common
Stock issuable and deliverable upon the exchange of shares of Series A Preferred Stock be issued
and delivered in the denominations indicated below to the registered holder hereof unless a
different name has been indicated below.

	 	 	 	 	 
	Dated:                           

	 
Fill in for registration of shares of Common Stock if to be issued otherwise
than to the registered holder:

	 	 	 
	Name
	 	 	 
	 	 	 
	Address (Please print name and address, including zip code)

	
 	 	 
	(Signature)

Denominations:                     

Exhibit A – Page 1exv4w3

 

Exhibit 4.3

FORM OF

WARRANT

to Purchase Common Stock of

Fremont General Corporation

 

 

THIS WARRANT IS NON-TRANSFERABLE OTHER THAN AS PROVIDED IN THE EXCHANGE AND SHAREHOLDER RIGHTS
AGREEMENT, DATED [•], 2007 (THE “EXCHANGE AND SHAREHOLDER RIGHTS AGREEMENT”).

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN INVESTMENT AGREEMENT, DATED MAY
21, 2007 (THE “INVESTMENT AGREEMENT”).

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE EXCHANGE AND SHAREHOLDER RIGHTS
AGREEMENT.

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED. THE SHARES OF COMMON STOCK OF FREMONT GENERAL CORPORATION UNDERLYING THIS
WARRANT ARE SUBJECT TO THE INVESTMENT AGREEMENT, THE EXCHANGE AND SHAREHOLDER RIGHTS AGREEMENT, AND
A REGISTRATION RIGHTS AGREEMENT, DATED [•], 2007. A COPY OF SUCH INVESTMENT AGREEMENT,
EXCHANGE AND SHAREHOLDER RIGHTS AGREEMENT, OR REGISTRATION RIGHTS AGREEMENT WILL BE FURNISHED
WITHOUT CHARGE BY THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST.

Warrant

to Purchase Shares of Common Stock of

Fremont General Corporation

     THIS IS TO CERTIFY THAT Hunter’s Glen/Ford, Ltd., a Texas limited partnership (the
“Investor”), or its permitted assigns, is entitled, subject to the terms and conditions set forth
herein, at any time and from time to time prior to the Expiration Date (as defined herein), to
purchase from Fremont General Corporation, a Nevada corporation (the “Company”), 7,129,326 shares
of Common Stock, at a purchase price of $8.44 per share (the initial “Exercise Price,” subject to
adjustment as provided herein).

	1.	 	DEFINITIONS

     As used in this Warrant, the following terms have the respective meanings set forth below:

     “Applicable Base Amount” shall mean $8.44 from the date hereof to (but excluding) the
Shareholder Approval Date, and shall mean $9.00 from (and including) and after the Shareholder
Approval Date.

     “Asset Purchase Agreement” means the Asset Purchase Agreement, dated as of May 21,
2007, between the Bank and iStar Financial Inc.

     “Bank” means Fremont Investment & Loan, a California industrial banking corporation.

 

 

     “CDI Litigation” means pending litigation (and related actions) brought against the
Company, its subsidiaries or its officers and directors by the California Insurance Commissioner
alleging, among other things, the improper utilization by the Company or its subsidiary of certain
net operating loss deductions and mismanagement claims.

     “Closing Price” means, for each trading day, the last reported sale price regular way
on the principal national securities exchange on which the Common Stock is then listed or admitted
for trading or, if the Common Stock is not listed on a national securities exchange, the average of
the closing bid and asked prices in the over-the-counter market as furnished by any New York Stock
Exchange member firm selected from time to time by the Company for that purpose.

     “Company” has the meaning assigned to it in the preamble, and any successor
corporation.

     “Current Market Price” means, on any day, the average of the Closing Prices of the
Common Stock for the ten consecutive trading days ending on such day.

     “Designated Office” has the meaning assigned to it in Section 6 hereof.

     “Exchange and Shareholder Rights Agreement” means that certain Exchange and
Shareholder Rights Agreement, dated [•], by and among the Company, the Bank and the Investor.

     “Excluded Stock” has the meaning assigned to it in Section 4.10 hereof.

     “Exercise Date” has the meaning assigned to it in Section 2.1(a) hereof.

     “Exercise Notice” has the meaning assigned to it in Section 2.1(a) hereof.

     “Exercise Price” means, in respect of a Warrant Share, the Exercise Price set forth in
the preamble of this Warrant, as adjusted from time to time pursuant to Section 4 hereof.

     “Expiration Date” means the first anniversary of the Reset Date.

     “Fair Market Value” means the amount which a willing buyer would pay a willing seller
in an arms-length transaction, as determined in good faith by the Company’s board of directors.

     “Fully Diluted Outstanding Shares” as of any date means the number of shares of Common
Stock outstanding on such date on a fully diluted basis (including, without limitation, shares of
restricted stock (whether or not vested) and, in accordance with the treasury method, shares
subject to outstanding stock options, whether or not “in the money”), excluding shares issued or
issuable upon exchange of Series A Preferred Stock or upon exercise of Warrants.

     “Holder” means (a) with respect to this Warrant, the Investor or such other Person in
whose name the Warrant is registered on the books of the Company maintained for such purpose and
(b) with respect to any Warrant Shares, the Person in whose name such Warrant Shares are registered
on the books of the Company maintained for such purpose.

2

 

     “Investment Agreement” means the Investment Agreement, dated as of May 21, 2007, by
and among the Company, the Bank and the Investor.

     “Investor” has the meaning assigned to it in the preamble.

     “Measurement Date” has the meaning set forth in the definition of “Reset Date.”

     “Original Issue Date” means [•], 2007, the date on which the Warrant was issued
by the Company pursuant to the Investment Agreement.

     “Quarter-End Date” has the meaning set forth in the definition of “Reset Date.”

     “Premium” means the amount to be paid for the Purchased Non-Loan Assets, as defined in
the Asset Purchase Agreement pursuant to Section 2.04(b) therein, or any successor provisions, not
to exceed $50,000,000.

     “Reset Date” means the date that is the 45th day after the earlier to occur
of (i) the last day of the Company’s fiscal quarter during which the Bank consummates the
Commercial Real Estate Transaction (the “Quarter-End Date”) and (ii) December 31, 2007 (the
“Year-End”) (the earlier to occur of the Quarter-End Date and the Year-End being referred to herein
as the “Measurement Date”).

     “Shareholder Approval” means the approval by the Company’s shareholders of the
issuance to the Investor of the Additional Warrant.

     “Shareholder Approval Date” means the date as of which the Shareholder Approval
occurs.

     “Tangible Book Value” means the positive difference, if any, of (a) the Company’s
consolidated assets (excluding goodwill, trademarks and other intangible assets) minus (b) the
Company’s consolidated liabilities, in each case as reported on the Company’s consolidated balance
sheet as of the Measurement Date, calculated in accordance with GAAP consistently applied with
prior periods: provided, however, that: (i) there shall be included in Tangible
Book Value, (A) the portion of the Premium, if any, not included in the earnings of the Company for
periods prior to the Measurement Date, multiplied by 57.954%, (B) an add-back in an amount equal to
the valuation allowance applied to the actual amount of deferred tax assets as of the Measurement
Date for Federal and California franchise tax purposes that may be realized prior to the expiration
of the applicable net operating loss carryforward periods; provided that the amount of such
add-back plus the amount of deferred tax assets for Federal and California franchise tax purposes
reflected on the consolidated balance sheet as of the Measurement Date shall not exceed
$150,000,000, (C) an add-back in an amount equal to any allowance for loan losses specifically
related to the A Participation Interest (as defined in the Asset Purchase Agreement) as of the
Measurement Date multiplied by 57.954%, and (D) the amount of any goodwill on the consolidated
balance sheet as of the Measurement Date related to acquisitions by the Company that were approved
by the Investor in writing and closed between the date of this Agreement and the Measurement Date
and (ii) there shall be excluded from Tangible Book Value, the effect of the issuance of the Series
A Preferred Stock and the Warrants. Tangible Book Value shall be

3

 

determined in good faith by the Board of Directors, subject to the approval of Investor, which
approval will not be unreasonably withheld.

     “Underpayment Test” has the meaning assigned to it in Section 4.13 hereof.

     “Warrant Price” means an amount equal to (i) the number of Warrant Shares being
purchased upon exercise of this Warrant pursuant to Section 2.1 hereof, multiplied
by (ii) the Exercise Price.

     “Warrant Shares” means the shares of Common Stock issuable upon the exercise of this
Warrant.

     “Year-End” has the meaning set forth in the definition of “Reset Date.”

     All other capitalized terms used but not defined herein shall have the meanings given to such
terms in the Exchange and Shareholder Rights Agreement.

	2.	 	EXERCISE OF WARRANT

     2.1. Manner of Exercise.

          (a) From and after the Original Issue Date and at any time before 5:00 P.M., New York
time, on the Expiration Date, the Holder may from time to time exercise this Warrant, on any
Business Day, in whole or in part. In order to exercise this Warrant, the Holder shall (i)
deliver to the Company at its Designated Office a written notice of the Holder’s election to
exercise this Warrant (an “Exercise Notice”) substantially in the form attached to this
Warrant as Annex A, which Exercise Notice shall be irrevocable and specify the
number of Warrant Shares to be purchased, together with this Warrant and (ii) pay to the
Company the Warrant Price in full. The date on which such delivery and payment shall have
taken place shall be hereinafter sometimes referred to as the “Exercise Date.” If the
Warrant has not been exercised by 5:00 P.M., New York time, on the Expiration Date, it shall
expire.

          (b) Upon receipt by the Company of such Exercise Notice, surrender of this Warrant and
payment of the Warrant Price (in accordance with Section 2.1(c) hereof), the Company shall,
as promptly as practicable, and in any event within five (5) Business Days thereafter,
execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder a
certificate or certificates representing the Warrant Shares issuable upon such exercise
registered in the name of the exercising Holder, together with cash in lieu of any fraction
of a share, as hereafter provided. The stock certificate or certificates so delivered shall
be, to the extent possible, in such denomination or denominations as the exercising Holder
shall reasonably request in the Exercise Notice and shall be registered in the name of the
exercising Holder or such other name as shall be designated in the Exercise Notice. This
Warrant shall be deemed to have been exercised and such certificate or certificates of
shares of Common Stock issuable upon exercise of this Warrant shall be deemed to have been
issued, and the Holder (or any other Person so designated to be named therein) shall be
deemed to have become a holder of record of such shares of Common Stock for all purposes, as
of the Exercise Date.

4

 

          (c) Payment of the Warrant Price shall be made at the option of the exercising Holder
in cash or by delivery of a certified or official bank check or bank cashier’s check payable
to the order of the Company, or by wire transfer of immediately available funds, in the
amount of such Warrant Price. Payment shall be made to the Company at its Designated Office
prior to the close of business on the Exercise Date.

          (d) All issuances of Common Stock pursuant to this Warrant shall be subject to
compliance with all applicable legal and bank regulatory requirements.

     2.2. Payment of Taxes. All shares of Common Stock issuable upon the exercise of this Warrant pursuant to the terms
hereof shall be validly issued, fully paid and nonassessable, issued without violation of any
preemptive or similar rights of any stockholder of the Company and free and clear of all Liens.
The Company will pay any and all expenses and original issuance, transfer, stamp and other similar
taxes that may be payable in respect of the issue or delivery of the Warrant Shares, unless such
tax or charge is imposed by law upon the Holder. In addition, the Company shall not be required to
pay any tax or governmental charge which may be issuable upon exercise of this Warrant payable in
respect of any Transfer involved in the issue and delivery of Warrant Shares in a name other than
that of the exercising Holder, and no such issue or delivery shall be made unless and until the
Person requesting such issue has paid to the Company the amount of any such tax, or has established
to the satisfaction of the Company that such tax has been paid or will be paid.

     2.3. Fractional Shares. The Company shall not be required to issue fractional shares of its Common Stock upon exercise
of any Warrant. In lieu of any fraction of a share to which any Holder would otherwise be
entitled, the Company shall make a cash payment equal to the product of such fraction multiplied by
the Current Market Price of one share of Common Stock on the Exercise Date.

	3.	 	TRANSFER, DIVISION AND COMBINATION

     3.1. Transfer of this Warrant.
This Warrant is non-transferable other than as provided in the Exchange and Shareholder Rights
Agreement, and any attempted transfer or assignment other than as set forth therein shall be void.
Upon compliance with the provisions of this Section 3.1, each transfer of this Warrant and all
rights hereunder, in whole or in part, shall be registered on the books of the Company to be
maintained for such purpose, upon surrender of this Warrant at the Designated Office and compliance
with the terms hereof, together with a written assignment of this Warrant in the form of Annex
B hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
transfer taxes described in Section 2.2 in connection with the making of such transfer. Upon such
compliance, surrender and delivery and, if required, such payment, the Company shall execute and
deliver a new Warrant or Warrants in the name of the assignee or assignees and in the denominations
specified in such instrument of assignment, and shall issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned and this Warrant shall promptly be
cancelled.

     3.2. Mutilation or Loss.
Upon receipt by the Company from the Holder of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Warrant and an indemnity reasonably
satisfactory to it (it being understood that the written

5

 

indemnification agreement or an affidavit of loss of the Holder shall be a sufficient
indemnity) and, in case of mutilation, upon surrender and cancellation hereof, the Company will
execute and deliver in lieu hereof a new Warrant of like tenor to such Holder; provided,
however, that, in the case of mutilation, no indemnity shall be required if this Warrant in
identifiable form is surrendered to the Company for cancellation. Upon the issuance of any new
Warrant under this Section 3.2, the Company may require the payment of a sum sufficient to cover
any tax or other governmental charge that may be imposed in relation thereto.

     3.3. Expenses. Except as provided in Section 3.2, the Company shall prepare, issue and deliver at its own
expense any new Warrant required to be issued hereunder.

     3.4. Maintenance of Books.
The Company agrees to maintain, at the Designated Office, books for the registration and
transfer of the Warrant.

	4.	 	ADJUSTMENT OF EXERCISE PRICE

     4.1.

          (a) If the Shareholder Approval Date occurs prior to the Reset Date, the Exercise Price
shall be increased to $9.00 per share, subject to adjustment from time to time in accordance
with this Section 4.

          (b) Effective 5:00 P.M., New York time, on each of the Reset Date and, if it occurs on
or after the Reset Date, the Shareholder Approval Date, the Exercise Price shall be reset to
the lesser of (a) the Applicable Base Amount or (b) an amount equal to the quotient of: (i)
the product of (x) 0.75 multiplied by (y) the Tangible Book Value as of the
Measurement Date, divided by (ii) the Fully Diluted Outstanding Shares as of the Measurement
Date. If, prior to the Reset Date, an adjustment of the Exercise Price has occurred
pursuant to Section 4.2, such adjustment(s) shall be made on the reset Exercise Price
determined by the immediately preceding sentence. If prior to the Reset Date the Holder
shall have already exercised all or any part of this Warrant, then the Company shall
promptly pay in cash to the Holder, in respect of all of the shares of Common Stock received
upon each such exercise, an amount equal to the positive difference, if any, of (i) the
amount by which (A) the sum of the amount paid hereunder by the Holder to the Company for
such shares of Common Stock in such exercise plus all amounts paid by the Holder to the
Company pursuant to Section 4.13 with respect to such shares exceeds (B) the sum of the
payments made by the Company to such Holder in connection with the actual exercise pursuant
to Sections 4.2 and 4.3 minus (ii) the amount the Holder would have paid to the
Company for such shares of Common Stock (and any additional shares subsequently acquired by
the Holder in respect of such shares pursuant to transactions contemplated by Sections 4.4,
4.6, and 4.7) in such exercise at the Exercise Price as adjusted pursuant to this Section
4.1 (giving effect to all prior adjustments under this Section 4). In the event that, prior
to the Reset Date or, if it occurs on or after the Reset Date, the Shareholder Approval
Date, the Exercise Price shall have been adjusted pursuant to Sections 4.4, 4.6 or 4.7, then
the Exercise Price shall be adjusted pursuant to the first sentence of this Section 4.1 as
if the event or events giving

6

 

rise to such adjustment(s) occurred immediately following the adjustment of the
Exercise Price pursuant to this Section 4.1.

     4.2. If, on the date a final non-appealable judgment is rendered in the CDI Litigation or a
final binding settlement agreement is entered into by the Company and its relevant subsidiaries
with respect to the CDI Litigation (the “Litigation Resolution Date”), the total costs incurred by
the Company or its subsidiaries related to the CDI Litigation after the Measurement Date
(including, without limitation, judgments, fines and penalties incurred in connection with the CDI
Litigation, but excluding costs incurred in connection with legal defense, consultant fees and any
other third party costs incurred in connection with the defense thereof) (the “Litigation Costs”)
exceed $35,000,000 (such excess being the “Litigation Cost Excess”), then the Exercise Price (after
taking into account the next sentence) shall be immediately adjusted downward by an amount equal to
the product of: (i) 0.75 multiplied by (ii) the quotient of (A) the positive
difference of the Litigation Cost Excess (net of any realizable income tax benefits attributable to
the Litigation Cost Excess) divided by (B) the Fully Diluted Outstanding Shares as
of the Measurement Date. In the event that, prior to the Litigation Resolution Date, the Exercise
Price shall have been adjusted pursuant to Sections 4.4, 4.6 or 4.7, then the Exercise Price shall
be adjusted pursuant to the preceding sentence as if the event or events giving rise to such
adjustment(s) occurred immediately following the adjustment of the Exercise Price pursuant to this
Section 4.2. If, however, as of the Litigation Resolution Date, the Holder has already exercised
all or any part of this Warrant, then, the Company shall promptly pay to the Holder in cash, in
respect of all the shares of Common Stock received upon each such exercise occurring prior to the
Litigation Resolution Date, an amount equal to the positive difference, if any, of (i) the amount
by which (A) the sum of the amount paid hereunder by the Holder to the Company for such shares of
Common Stock in such exercise plus all amounts paid by the Holder to the Company pursuant to
Section 4.13 with respect to such shares exceeds (B) the sum of the payments made by the Company to
such Holder in connection with such exercise pursuant to Sections 4.1 and 4.3 minus (ii)
the amount the Holder would have paid to the Company for such shares of Common Stock (and any
additional shares subsequently acquired by the Holder in respect of such shares pursuant to
transactions contemplated by Sections 4.4, 4.6, and 4.7) in such exercise at the Exercise Price as
adjusted pursuant to this Section 4.2 (giving effect to all prior adjustments under this Section 4)
(such aggregate cash payment by the Company being referred to herein as the “Litigation Settlement
Amount”), provided, however, that if the Company does not have sufficient cash to
make such payment or is legally or contractually prohibited from making such payment, the Company
shall pay such Litigation Settlement Amount in a number of shares of Common Stock equal to the
quotient of the Litigation Settlement Amount divided by the Current Market Price.

     4.3. If, on June 30, 2010, the total cumulative losses (excluding losses attributable to early
payment defaults), liabilities or expenses incurred by the Company and its Subsidiaries on a
consolidated basis after the Measurement Date relating to the rights or claims of third parties in
connection with mortgage loans sold (whether as a whole loan sale, securitization or otherwise) by
the Company or any of its Subsidiaries prior to the Measurement Date (the “Loan Losses”) exceed the
sum of $35,000,000 plus a new reserve established on the Company’s consolidated balance
sheet at June 30, 2007 (excluding any reserve for early payment defaults) (prepared in accordance
with GAAP consistently applied with prior periods) in connection with such loans (such excess being
the “Loan Loss Excess”), then the Exercise Price (after taking into account

7

 

the next sentence) shall be adjusted downward on such date by an amount equal to the product
of: (i) 0.75 multiplied by (ii) the quotient of (A) the Loan Loss Excess (net of
any realizable income tax benefits attributable to the Loan Loss Excess) divided by
(B) the Fully Diluted Outstanding Shares as of the Measurement Date. In the event that, prior to
June 30, 2010, the Exercise Price shall have been adjusted pursuant to Sections 4.4, 4.6 or 4.7,
then the Exercise Price shall be adjusted pursuant to the preceding sentence as if the event or
events giving rise to such adjustment(s) occurred immediately following the adjustment of the
Exercise Price pursuant to this Section 4.3. If, however, as of June 30, 2010, the Holder has
already exercised all or any part of this Warrant, then the Company shall promptly pay to the
Holder in cash, in respect of all of the shares of Common Stock received upon each such exercise
occurring prior to June 30, 2010, an amount equal to the positive difference, if any, of (i) the
amount by which (A) the sum of the amount paid hereunder by the Holder to the Company for such
shares of Common Stock in such exercise plus all amounts paid by the Holder to the Company pursuant
to Section 4.13 with respect to such shares exceeds (B) the sum of the payments made by the Company
to such Holder in connection with the actual exercise pursuant to Sections 4.1 and 4.2
minus (ii) the amount the Holder would have paid to the Company for such shares of Common
Stock (and any additional shares subsequently acquired by the Holder in respect of such shares
pursuant to transactions contemplated by Sections 4.4, 4.6, and 4.7) in such exercise at the
Exercise Price as adjusted pursuant to this Section 4.3 (giving effect to all prior adjustments
under this Section 4) (such aggregate cash payment by the Company being referred to herein as the
“Loan Loss Settlement Amount”); provided, however, that if the Company does not
have sufficient cash to make such payment or is legally or contractually prohibited from making
such payment, the Company shall pay such Loan Loss Settlement Amount in a number of shares of
Common Stock equal to the quotient of the Loan Loss Settlement Amount divided by the Current Market
Price.

     4.4. Upon Issuance of Common Stock. If the Company shall, at any time or from time to time after the Original Issue Date and on or
before the Expiration Date, issue any shares of Common Stock, options to purchase or rights to
subscribe for Common Stock, securities by their terms convertible into or exchangeable for Common
Stock, or options to purchase or rights to subscribe for such convertible or exchangeable
securities without consideration or for consideration per share less than the Current Market Price,
then the Exercise Price shall forthwith be lowered to a price equal to the price obtained by
multiplying:

          (a) the Exercise Price in effect immediately prior to the issuance of such Common
Stock, options, rights or securities by

          (b) a fraction of which (x) the numerator shall be the sum of (A) the number of shares
of Common Stock outstanding on a fully diluted basis immediately prior to such issuance and
(B) the number of additional shares of Common Stock which the aggregate consideration for
the number of shares of Common Stock so offered would purchase at the Current Market Price
and (y) the denominator shall be the number of shares of Common Stock outstanding on a fully
diluted basis immediately after such issuance.

The provisions of this Section 4.4 shall not apply to any issuance of Excluded Stock.

8

 

     4.5. Provisions Applicable to Adjustments. For the purposes of any adjustment of the Exercise Price pursuant to Section 4.4, the
following provisions shall be applicable:

          (a) In the case of the issuance of Common Stock for cash in a public offering or
private placement, the consideration shall be deemed to be the amount of cash paid therefor
before deducting therefrom any discounts, commissions or placement fees payable by the
Company to any underwriter or placement agent in connection with the issuance and sale
thereof.

          (b) In the case of the issuance of Common Stock for consideration in whole or in part
other than cash, the consideration other than cash shall be deemed to be the Fair Market
Value thereof.

          (c) In the case of the issuance of options to purchase or rights to subscribe for
Common Stock, securities by their terms convertible into or exchangeable for Common Stock,
or options to purchase or rights to subscribe for such convertible or exchangeable
securities (except for options to acquire or rights to subscribe for, or securities
convertible into or exchangeable for, Excluded Stock):

     (i) the aggregate maximum number of shares of Common
Stock deliverable upon exercise of any such options to
purchase or rights to subscribe for Common Stock shall be
deemed to have been issued at the time such options or rights
were issued and for a consideration equal to the
consideration (determined in the manner provided in
subparagraphs (a) and (b) of this Section 4.5), if any,
received by the Company upon the issuance of such options or
rights plus the minimum purchase price provided in
such options or rights for the Common Stock covered thereby;

     (ii) the aggregate maximum number of shares of Common
Stock deliverable upon conversion of or in exchange for any
such convertible or exchangeable securities or upon the
exercise of options to purchase or rights to subscribe for
such convertible or exchangeable securities and subsequent
conversion or exchange thereof shall be deemed to have been
issued at the time such securities, options, or rights were
issued and for a consideration equal to the consideration
received by the Company for any such securities and related
options or rights, plus the additional consideration,
if any, to be received by the Company upon the conversion or
exchange of such securities or the exercise of any related
options or rights (the consideration in each case to be
determined in the manner provided in paragraphs (a) and (b)
of this Section 4.5);

9

 

     (iii) on any change in the number of shares or exercise
price of Common Stock deliverable upon exercise of any such
options or rights or conversions of or exchanges for such
securities, other than a change resulting from the
anti-dilution provisions thereof, the Exercise Price shall
forthwith be readjusted to such Exercise Price as would have
been obtained had the adjustment made upon the issuance of
such options, rights or securities not converted prior to
such change or options or rights related to such securities
not converted prior to such change been made upon the basis
of such change;

     (iv) upon the expiration of any options to purchase or
rights to subscribe for Common Stock which shall not have
been exercised, the Exercise Price computed upon the original
issue thereof (or upon the occurrence of a record date with
respect thereto), and any subsequent adjustments based
thereon, shall, upon such expiration, be recomputed as if the
only additional shares of Common Stock issued were the shares
of Common Stock, if any, actually issued upon the exercise of
such options to purchase or rights to subscribe for Common
Stock, and the consideration received therefor was the
consideration actually received by the Company for the issue
of the options to purchase or rights to subscribe for Common
Stock that were exercised, plus the consideration actually
received by the Company upon such exercise; and

     (v) no further adjustment of the Exercise Price adjusted
upon the issuance of any such options, rights, convertible
securities or exchangeable securities shall be made as a
result of the actual issuance of Common Stock on the exercise
of any such rights or options or any conversion or exchange
of any such securities.

     4.6. Upon Stock Dividends, Subdivisions or Splits. If, at any time after the Original Issue Date and on or before the Expiration Date, the number
of shares of Common Stock outstanding is increased by a stock dividend payable in shares of Common
Stock or by a subdivision or split up of shares of Common Stock, then, following the record date
for the determination of holders of Common Stock entitled to receive such stock dividend, or to be
affected by such subdivision or split up, the Exercise Price shall be appropriately decreased to
equal the product of the Exercise Price multiplied by a fraction, the numerator of which is the
number of shares of Common Stock outstanding immediately prior to such increase and the denominator
of which is the number of shares of Common Stock outstanding immediately after such increase.

10

 

     4.7. Upon Combinations or Reverse Stock Splits. If, at any time after the Original Issue Date, the number of shares of Common Stock
outstanding is decreased by a combination or reverse stock split of the outstanding shares of
Common Stock into a smaller number of shares of Common Stock, then, following the record date to
determine shares affected by such combination or reverse stock split, the Exercise Price shall be
appropriately increased to equal the product of the Exercise Price multiplied by a fraction, the
numerator of which is the number of shares of Common Stock outstanding immediately prior to such
decrease and the denominator of which is the number of shares of Common Stock outstanding
immediately after such decrease in outstanding shares.

     4.8. Upon Reclassifications, Reorganizations, Consolidations or Mergers.
In the event of any capital reorganization of the Company, any reclassification of the stock
of the Company (other than a change in par value or from par value to no par value or from no par
value to par value or as a result of a stock dividend or subdivision, split up or combination of
shares), or any consolidation or merger of the Company with or into another Person (where the
Company is not the surviving Person or where there is a change in or distribution with respect to
the Common Stock), each Warrant shall after such reorganization, reclassification, consolidation,
or merger be exercisable for the kind and number of shares of stock or other securities or property
of the Company or of the successor Person resulting from such consolidation or surviving such
merger, if any, to which the holder of the number of shares of Common Stock deliverable
(immediately prior to the time of such reorganization, reclassification, consolidation or merger)
upon exercise of such Warrant would have been entitled upon such reorganization, reclassification,
consolidation or merger. The provisions of this clause shall similarly apply to successive
reorganizations, reclassifications, consolidations, or mergers. The Company shall not effect any
such reorganization, reclassification, consolidation or merger unless, prior to the consummation
thereof, the successor Person (if other than the Company) resulting from such reorganization,
reclassification, consolidation or merger, shall assume, by written instrument, the obligation to
deliver to the Holder such shares of stock, securities or assets, which, in accordance with the
foregoing provisions, such Holder shall be entitled to receive upon such conversion.

     4.9. Deferral in Certain Circumstances. In any case in which the provisions of this Section 4 shall require that an adjustment shall
become effective immediately after a record date of an event, the Company may defer until the
occurrence of such event (a) issuing to the Holder with respect to any Warrants exercised after
such record date and before the occurrence of such event the shares of Common Stock issuable or
cash payable upon such exercise by reason of the adjustment required by such event and issuing to
such Holder only the shares of Common Stock issuable upon such exercise before giving effect to
such adjustments, and (b) paying to such Holder any amount in cash in lieu of a fractional share of
Common Stock pursuant to Section 2.3 above; provided that the Company shall deliver to such
Holder an appropriate instrument or due bills evidencing such Holder’s right to receive such
additional shares or such cash.

     4.10. Adjustment of Number of Shares Purchasable. Upon any adjustment of the Exercise Price as provided in Sections 4.4, 4.6, or 4.7 Holders of
the Warrants shall thereafter be entitled to receive upon the exercise thereof, at the Exercise
Price resulting from such adjustment, the number of shares of Common Stock (calculated to the
nearest 1/100th of a share) obtained by multiplying the Exercise Price in effect immediately prior
to such adjustment by the number of shares of Common Stock issuable on the exercise hereof
immediately prior to such

11

 

adjustment and dividing the product thereof by the Exercise Price resulting from such
adjustment.

     4.11. Form of Warrant. Irrespective of and without limiting any adjustment in the Exercise Price or the number of
shares purchasable upon the exercise of the Warrant, Warrants thereafter issued may continue to
express the same price and number and kind of shares as are stated in the original Warrant.

     4.12. Exceptions. This Section 4 shall not apply to any shares of Common Stock (a) issued as consideration when
any corporation or business is acquired, merged into, or becomes part of the Company or a
subsidiary of the Company, (b) issued upon exercise of any options, warrants or other rights
assumed by the Company in connection with a merger or other acquisition, provided, that
such options, warrants or other rights assumed by the Company shall not have been issued in
connection with or in contemplation of such merger or acquisition, (c) issued in good faith in
connection with any other acquisition of assets in an arms-length transaction between the Company
and an unaffiliated third party, (d) issued upon exchange of the Preferred Shares as contemplated
by the Exchange and Shareholder Rights Agreement, (e) issued to employees or directors of the
Company pursuant to an employee stock option plan or stock incentive plan approved by the Board of
Directors at no less than market value on the date of grant, or (f) issued to officers and
employees pursuant to employment agreements in existence on the date hereof at no less than market
value on the date of issuance (collectively, the “Excluded Stock”). Additionally, no further
adjustments to the Exercise Price shall be made under Sections 4.2 or Section 4.3 from and after
the date the Permitted Holders cease to beneficially own and/or have the right to acquire at least
5% of the Aggregate Initial Shares.

     4.13. Shareholder Approval Date Adjustment. If, prior to the Shareholder Approval Date, all or any portion of this Warrant has been
exercised and shares of Common Stock have been purchased pursuant thereto, then, within five
Business Days after the Shareholder Approval Date, the Holder shall pay to the Company, in respect
of all the shares of Common Stock so purchased, an amount in cash such that the net amount paid by
such Holder (or its predecessors) to the Company (i.e., net of any payments received by the Holder
from the Company under this Section 4) in respect of all such share purchases equals the net amount
such Holder (or its predecessors) would have been obligated to pay to the Company in respect of
such purchases if the Shareholder Approval had occurred prior to such exercises (the “Underpayment
Test”). If the Underpayment Test is satisfied without a payment by the Holder to the Company, then
the Holder shall not be required to pay any amount under this Section 4.13.

	5.	 	TAKING OF RECORD; TRANSFER BOOKS; WARRANT HOLDER NOT DEEMED A STOCKHOLDER

     5.1. Taking of Record. In the case of dividends or other distributions by the Company to the holders of its Common
Stock with respect to which any provision hereof refers to the taking of a record of such holders,
the Company will in each such case take such a record and will take such record as of the close of
business on a Business Day.

     5.2. Closing of Transfer Books. The Company shall not at any time close its stock transfer books so as to result in preventing
or delaying the exercise of the Warrant.

12

 

     5.3. Warrant Holder Not Deemed a Stockholder. The Company may deem and treat the registered Holder of the Warrant as the absolute owner
thereof (notwithstanding any notation of ownership or other writing thereon made by anyone), for
the purpose of any exercise thereof and for all other purposes, and neither the Company nor any
agent thereof shall be affected by any notice to the contrary. Accordingly, the Company shall not
be bound to recognize any equitable or other claim to, or interest in, the Warrant on the part of
any Person other than such registered Holder, whether or not it shall have express or other notice
thereof. Prior to the valid exercise of the Warrant, no Holder of the Warrant, as such, shall be
entitled to any rights of a stockholder of the Company, including, without limitation, the right to
vote or to consent to an action of the stockholders, to receive dividends or other distributions,
to exercise any preemptive right, or to receive any notice of meetings of stockholders and, except
as otherwise provided in the Investment Agreement, shall not be entitled to receive any notice of
any proceedings of the Company.

	6.	 	OFFICE OF THE COMPANY

     As long as the Warrant remains outstanding, the Company shall maintain an office or agency,
which may be the principal executive offices of the Company (the “Designated Office”), where the
Warrant may be presented for exercise, registration of transfer, division or combination as
provided in this Warrant. Such Designated Office shall initially be the office of the Company at
2425 Olympic Boulevard, Santa Monica, California 90404. The Company may from time to time change
the Designated Office to another office of the Company or its agent within the United States by
notice given to all registered Holders at least ten (10) Business Days prior to the effective date
of such change.

	7.	 	MISCELLANEOUS

     7.1. No Implied Waivers.
No failure or delay by any party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or
further exercise thereof or the exercise of any other right, power or privilege. The rights and
remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided
by law.

     7.2. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have
been duly given, if delivered personally, by telecopier or sent by first class mail, postage
prepaid, as follows:

	 	(a)	 	If to the Company, to:

	 	 	 
	 
	 	Fremont General Corporation
	 
	 	2425 Olympic Boulevard
	 
	 	Santa Monica, CA 90404
	 
	 	Attention:  General Counsel
	 
	 	Fax:  (310) 315-5593
	 
	 	 
	 
	 	With a copy to:

13

 

	 	 	 
	 
	 	Skadden, Arps, Slate, Meagher & Flom LLP
	 
	 	Four Times Square
	 
	 	New York, NY 10036
	 
	 	Attention: William S. Rubenstein, Esq.
	 
	 	Fax: (917) 777-2642

	 	(b)	 	If to the Investor, to:

	 	 	 
	 
	 	Hunter’s Glen/Ford, Ltd.
	 
	 	200 Crescent Court, Suite 1350
	 
	 	Dallas, TX 75201
	 
	 	Attention: Randy Staff
	 
	 	Fax: (214) 871-5122
	 
	 	 
	 
	 	With a copy to:
	 
	 	Gibson, Dunn & Crutcher LLP
	 
	 	333 South Grand Avenue
	 
	 	Los Angeles, California 90071
	 
	 	Attention: Dhiya El-Saden, Esq.
	 
	 	Fax: (213) 229-6196

14

 

     7.3. Limitation of Liability. No provision hereof, in the absence of affirmative action by the Holder to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder hereof, shall give rise
to any liability of such Holder to pay the Exercise Price for any Warrant Shares other than
pursuant to an exercise of this Warrant or any liability as a stockholder of the Company, whether
such liability is asserted by the Company or by creditors of the Company.

     7.4. Remedies. Each Holder of Warrants, in addition to being entitled to exercise its
rights granted by law, including recovery of damages, shall be entitled to specific performance of
its rights provided under this Warrant. The Company agrees that monetary damages would not be
adequate compensation for any loss incurred by reason of a breach by it of the provisions of this
Warrant and hereby agrees, in an action for specific performance, to waive the defense that a
remedy at law would be adequate.

     7.5. Successors and Assigns. This Warrant and the rights and obligations evidenced
hereby shall inure to the benefit of and be binding upon the successors of the Company and the
permitted successors and assigns of the Holder hereof.

     7.6. Amendment. This Warrant may be modified or amended only with the written consent
of the Company and the Holder.

     7.7. Severability. Wherever possible, each provision of this Warrant shall be
interpreted in such manner as to be effective and valid under applicable law, but if any provision
of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of
such provision or the remaining provisions of this Warrant.

     7.8. Headings. The headings and other captions in this Warrant are for convenience
and reference only and shall not be used in interpreting, construing or enforcing any provision of
this Warrant.

     7.9. Governing Law; Consent to Jurisdiction. This Warrant shall be governed by, and
interpreted in accordance with, the laws of the State of New York applicable to contracts made and
to be performed in that state. Each of the parties hereto (a) consents to submit itself to the
personal jurisdiction of any Federal or state court located in the State of California in the event
any dispute arises out of this Warrant or the transactions contemplated hereby, (b) agrees that it
will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave
from any such court and (c) agrees that it will not bring any action relating to this Warrant or
the transactions contemplated hereby in any court other than a Federal or state court located in
the State of California.

     7.10. Entire Agreement. This Warrant contains the entire agreement with respect to
the subject matter hereof and supersedes and replaces all other prior agreements, written or oral,
with respect to the subject matter hereof.

15

 

     7.11. Waiver of Jury Trial. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY
AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY.

[Execution Page Follows]

16

 

     IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the Original
Issue Date.

	 	 	 	 	 
	 	FREMONT GENERAL CORPORATION

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	Agreed to and Accepted

as of the Original Issue Date:

HUNTER’S GLEN/FORD, LTD.

 	 	 
	By:  	
 	 	 
	 	Name:  	 	 	 
	 	Title:  	 	 	 
	 

[Execution Page to the Warrant]

17

 

ANNEX A

SUBSCRIPTION FORM

[To be executed only upon exercise of Warrant]

     The undersigned registered owner of this Warrant irrevocably exercises this Warrant for the
purchase of                 
shares of Common Stock of Fremont General Corporation and herewith makes payment
therefor in                     , all at the price and on the terms and conditions specified in this Warrant
and requests that certificates for the shares of Common Stock hereby purchased (and any securities
or other property issuable upon such exercise) be issued in the name of and delivered to
                                         whose address is

 

	 	 	 	 	 
	 
	 	 	 	 
	 
	 	 
(Name of Registered Owner)	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	 
	 	 
(Signature of Registered Owner)	 	 
	 
	 	 	 	 
	 
	 	 
(Street Address)	 	 
	 
	 	 	 	 
	 
	 	 
(City)  (State)  (Zip Code)	 	 

			
	NOTICE:	 	The signature on this subscription must correspond with the name
as written upon the face of the within Warrant in every
particular, without alteration or enlargement or any change
whatsoever.

 

 

ANNEX B

ASSIGNMENT FORM

     FOR VALUE RECEIVED the undersigned registered owner of this Warrant hereby sells, assigns and
transfers unto the assignee named below all of the rights of the undersigned under this Warrant,
with respect to the number of shares of Common Stock set forth below:

	 	 	 
	 	 	No. of Shares of
	Name and Address of Assignee	 	Common Stock
	 
	 	 

and does hereby irrevocably constitute and appoint                                                               attorney in fact to
register such transfer onto the books of Fremont General Corporation maintained for the purpose,
with full power of substitution in the premises.

	 	 	 	 	 	 	 	 	 	 	 
	Dated:
	 	 	 	Print Name:	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Signature:
	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	Witness:	 	 	 	 

			
	NOTICE:	 	The signature on this assignment must correspond with the name as written upon the face of
the within Warrant in every particular, without alteration or enlargement or any change
whatsoever.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}]]